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Much attention has focussed in recent months on the impact that COVID-19 has on health sector 
capacity, including critical care bed capacity and resources such as personal protective equipment. 
However, much less attention has focussed on the overall cost to health sectors, including the full 
human resource costs and the health system costs to address the pandemic. Here we present 
estimates of the total costs of COVID-19 response in low- and middle-income countries for different 
scenarios of COVID-19 mitigation over a one year period. We find costs vary substantially by setting, 
but in some settings even mitigation scenarios place a substantial fiscal impact on the health system. 
We conclude that the choices facing many low- and middle- income countries, without further rapid 
emergency financial support, are stark, between fully funding an effective COVID-19 reponse or 
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This is preliminary report that has not yet been peer reviewed. These estimates should not yet 
guide policy in specific countries nor be reported as established information. We are placing these 
in the public domain to inform those who are estimaing Covid costs in low- and middle- income 
countries about the methods and assumptions required; higlight the broad level of fiscal impact 
and to invite comments for others working in this field, prior to submission to peer review 
publication. 
These estimates have been subjected to a detailed validation and error checking process internally. 
Nevertheless, given the dearth of data to inform Covid cost estimates at this time, our results 
depend on a range of assumptions. Comments and suggestions to improve this work are welcomed 
and can be sent to the authors below
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Introduction 
Since the declaration of Coronavirus Disease 2019 (COVID-19) as a public health emergency of 
international concern by the World Health Organization (WHO) in January 2020 [1], the disease has 
affected more than 22 million people and caused nearly 290,000 deaths worldwide [2]. While only a 
minority of cases will experience severe (15%) or critical (5%) disease that requires hospitalisation 
[3], the estimated costs of implementing WHO pandemic response guidelines in low- and middle-
income countries (LMICs) are potentially substantial [4]. These estimates are all the more staggering 
in the context of over-stretched LMIC health systems, whose capacity to expand the provision of 
critical care was already limited before the COVID-19 pandemic [5, 6].  
While there are financial costing tools available for countries to plan their short term resource 
requirements  [7-9], there are few published estimates of the medium-term economic costs of 
prevention, tracing and treatment of COVID-19 cases for different epidemic scenarios to inform 
policy choice and longer term investment.  Reliable economic cost estimates are essential for 
economic evaluations and priority setting around COVID-19 interventions. They can be used for 
example, to estimate potential cost savings from new COVID-19 vaccines as these become available’ 
as well as for informing policy choices seeking to balance the broader macro-economic costs of 
mitigation strategies against the costs to the health system.  Although to date, much of the policy 
concern rightly focuses on the sizeable health and macro-economic impact of COVID-19 in LMICs, it 
is important that the health sector costs of COVID-19 are also considered as the opportunity costs of 
the health sector response to COVID-19 on other health areas may be high [10, 11].   
Most available cost data to inform these analyses is from high-income countries and/or does not 
encompass the full COVID-19 response cascade, nor the underlying health system costs [12-14]. To 
date, there is only one set of economic cost estimates from Kenya that takes into account low-cost 
case management scenarios appropriate to resource-constrained LMIC settings [15]. This paper 
presents the first study aiming to project the economic burden of COVID-19 response to LMIC health 
systems under different pandemic mitigation scenarios in the medium term.  
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Methods 
Epidemiological scenarios 
Our estimates of COVID-19 cases for different scenarios come from the epidemiological model 
produced by the London School of Hygiene and Tropical Medicine, estimating the health impact of 
COVID-19 for 92 LMICs (https://cmmid.github.io/topics/covid19/LMIC-projection-reports.html). For 
each country, the model produces estimates on the number of cases, hospitalisations, number of 
days in hospital for severe cases (general ward) and critical cases (intensive care unit), and deaths for 
57 distinct epidemiological scenarios over a one year period [16]. 
For the costing, four epidemiological scenarios were chosen out of the set of 57 possible scenarios. 
Scenario 1 represents an unmitigated epidemic. The other three scenarios were chosen because 
they represent a range of plausible policy options from highly mitigated to more moderate 
approaches (scenarios 4,14 and 49). Descriptions of the scenarios are presented below in Table 1. 
Further details can be found in the references above, and the numbers of cases, hospitalisations and 
bed-days for each country in Supplement S1. 
 
Defining the COVID-19 health sector response 
In line with the World Health Organisation we costed six priority areas of health sector response 
COVID-19: a) emergency response mechanisms at the national level; b) risk communication and 
community engagement; c) case finding, contact tracing and management; d) surveillance; e) public 
health measures; and, f) case management. For each of these we estimated a unit cost as per Table 
2 below.  
Our aim was to estimate a ‘real world’ cost that reflects local prices and resource use, and models of 
service delivery that are considered feasibile given resource constraints in low- and middle-income 
countries, rather than a full normative costing of national or global guidelines.   
To estimate the activity level average (unit) costs for each of the above we used an ingredients 
based costing approach. Our basis for prices and resource use was recent local cost and resource use 
data from three countries: Ethiopia (low income country), Pakistan (lower middle income country, 
and South Africa (upper middle income country). We selected these countries as we were not able 
to collect primary cost data directly from COVID-19 service delivery points, so chose countries where 
we had recently conducted large scale costing exercises around either tuberculosis (TB) or general 
health services. This gave us current local data on actual resource use, input prices and health 
system unit cost data for services such as outpatient consultations, inpatient bed-days, a range of 
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laboratory tests, including PCR tests and contact tracing. In the case of Ethiopia and South Africa, we 
had recent data from TB studies. In the case of Pakistan, the research team had been working with 
the Ministry of Health in 2019/20 to collect ingredients costs for all essential services as part of the 
Disease Control Priorities Project (DCP). While not primary data collection, all costs were subjected 
to a review by technical working groups as part of DCP that included practitioners at all levels of the 
health system. Members of the working groups were asked to consider feasibility as they reviewed 
and adapted the costs of different essential services.  
To adapt this prior data on costs to COVID-19, we then used a combination of: review of COVID-19 
resource planning tools and budgets, detailed expert consultation both with international and local 
experts and literature searches on primary cost data collection on the costs of clinical care in LMICs.  
Clinical management costs were based on expert consultation on essential critical care, including a 
detailed estimation of oxygen therapy needs;  and considering recent cost data collection on critical 
care in LMICs20; and, length of stay  and prevalence of complications from China. While we had 
access and reviewed length of stay data from different LMICs, this revealed either exceptionally high 
(early cases) or low (during surge) lengths of stay, and therefore the early data from China across the 
whole epidemic were felt to be the best estimate of a length of stay (considering those who die 
during care). Supplement S1 contains the summary level units used for each activity and the unit 
costs of each, and all assumptions used, including a comparison between normative 
recommendations for clinical case management and the assumptions used in this costing, based on 
expert consultation of feasibilty. 
We then extrapolated the detailed ingredients costing done for Ethiopia, Pakistan and South Africa 
to low, lower middle, and upper middle income countries respectively. Each cost input in the 
ingredients costing was classified as a tradeable good, non-tradeable good, or staff cost. To convert 
the tradeable good from the base country (e.g. Ethiopia) to a ‘second’ country (e.g. Afghanistan) we 
apportioned the percentage of the unit cost that was composed of tradeable goods in 2019 US$ 
from the base country to the second country.    
Non-tradeable goods include buildings, heavy machinery, and other equipment. To convert these 
costs from a base country to a second country we used purchasing power parity (PPP) conversion 
rates. We multiplied the proportion of the unit cost that was defined as non-tradeable (in 2019 US$) 
by the ratio of the 2019 GDP per capita (adjusted for PPP) of the second county, divided by the 2019 
GDP per capita (adjusted for PPP) of the base country. Data on GDP per capita (adjusted for PPP) can 
be found in the World Bank database [17].  
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To convert staff costs from a base country to a second country we used conversion rates from Serje 
et al (2018) [18]. Serje et al (2018) use regression analysis on a dataset containing wages from health 
workers of different skill levels for 193 countries in order to predict wages by country income level 
relative to GDP per capita. We used the GDP per capita multipliers presented in the paper in order to 
convert the staff wages from the base country to the second country.  
Finally, we then estimate the total cost of each scenario, against the % of government and total 
health expenditure in each country and gross domestic product.   
 
Results 
Our combined primary data and expert reviewed ingreidents costs of managing a mild case with 
home visits from health care providers ranged from $13 (Pakistan) to $147 (South Africa) per case. 
Hospital-based care for a severe case ranged from $33.32 (Pakistan) to $106 (South Africa) per day, 
while costs for a critical case were much higher at $221 (Pakistan) - $1,082 (South Africa) per day in 
hospital (see supplmentary results appendix Table SR1).  Table 2 shows our estimates of the mean 
unit cost per activity when these costs are extrapolated for low-income, lower-middle income, and 
upper-middle income countries. Table 2 includes the costs of managing the national emergency 
response mechanisms, risk communication and community engagement, case finding and 
surveillance, public health measures, screening and diagnosis, and case management.  
Average cost per capita by country income category are reported in Table 3, considering the total 
number of cases, and other units. Table SR2 and SR3 show the underlying costs per capita and total 
estimated annual costs per country, by intervention scenario.  For example, an unmitigated epidemic 
would cost an average of $5.2 billion per country, ranging from $11.3 million in Sao Tome and 
Principe to $127.8 billion in India. This is equivalent to an average of $50 per capita in LIC, $62 in 
LMIC, and $84 in UMIC (Table SR2). A 30-day lockdown would reduce these annual costs to an 
average of $4.66 billion (10.3M – 115.1B), or $44-$74/capita. An intervention resulting in social 
distancing of 20% year-round would further reduce costs to 3.84 billion (8.86M-96.08B), or $37-
$60/capita. Finally, an intervention leading to generalized social distancing of 60% year-round would 
to costs that are on average less than half those of the unmitigated epidemic (5.15M-58.56B or $21-
36 percapita).  
In all scenarios, costs of the COVID-19 response were predominantly attributable to screening and 
diagnosis and case management, particularly management of critical cases (Table 4). Case finding, 
contact tracing and surveillance, and public health measures in contrast made up less than 5% of the 
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total response costs. National-level costs of coordinating the emergency response and risk 
communication likewise constituted a small proportion of overall costs, amounting to less than 1% 
of total costs on average. The maps in Figures 1a and 1b show the extent to which total costs 
increase with less stringent social distancing policies, and how social distancing can be more 
effective than temporary lockdown at containing costs.   
Our sensitivity analysis (presented in Table SR8) shows that our estimates are partricularly sensitive 
to our assumptions on the number of symptomatic cases tested.  Doubling the estimated number of 
symptomatic cases tested from 10% to 20% increased our ‘unmitigated’ cost estimates from $50-
$84/capita to $57-$90/capita. A ten-fold increase in the number of symptomatic cases tested, from 
10% to 100%, resulted in nearly doubling our ‘unmitigated’ cost estimates to $121-137 per capita. 
The effect of this assumption was constant across all scenarios. 
 
Discussion 
We find  that the costs to health sector of responding to COVID-19 are substantial in LMICs, even 
when estimating the costs of essential critical care only. High levels of social distancing, however, 
may halve these costs within a one year period compared to allowing the pandemic to proceed in an 
unmitigated manner in the first year. The total cost and the costs as a proportion of health 
expenditue and GDP vary substantially across countries, with some countries likely to be able to 
‘afford’ the costs, and for others the financial impact of COVID-19 on the health sector in its first 
year being higher than normal annual costs for the health sector in totality.  
Our methods are subject to many limitations. Normally we would estimate ‘real world’ costs 
collecting extensive primary cost data on actual service delivery. In the case of COVID-19, we have 
not been able to do this. We have therefore had to rely substantially on data collected for other 
purposes and on expert opinion from LMICs to make key assumptions on how services may be 
delivered. We aimed to include the total costs to the health system and our aim was to estimate 
‘real world costs’ in terms of the resource needs to deliver the most essential care. However, our 
costs are unlikely to reflect actual expenditures, as countries may either provide more care to 
specific patients, or struggle to provide even the most essential care given the current restrictions on 
expenditure. Likewise, the case numbers that our estimates rely upon are unlikely to match the real 
case numbers currently being observed in many LMICs, as they represent single policy options, and a 
time period of one year from the start of the epidemic. Finally, we do not include the costs of 
protecting health care workers delivering other essential services outside the COVID-19 response. 
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Despite these limitations, our work highlights several critical qualitative recommendations for those 
working in COVID-19 policy. First, it is imperative, that global agencies and funders continue to act to 
ensure sufficient resources are made available globally for LMICs to respond, as the epidemic 
evolves. While much of the focus is on the macro-economic impact of COVID-19 and mortality 
impact, the fiscal impact on the health sector is likely to be substantial also needs to be considered if 
health systems in LMICs are to continue to deliver health services effectively. Second, it is clear that 
some countries are much more vulnerable to fiscal impact on the health sector than others. While 
specific short term financing needs for COVID-19 will fluctuate considerably over time, we highlight 
that some countries fundamentally will struggle to cope with almost any COVID-19 scenario, 
whereas others may be less vulnerable; which could help target support. Finally, our results 
demonstrate the myriad decisions about care, protection and patient experience that are required 
to plan resource needs of the response for which there is little discussion or data on what is feasible 
in LMICs. This is a task that cannot be met using a global perspective, but need country specific input 
to reflect the specific health system characteristics of each country. We therefore also call for urgent 
support to encourage interaction of economists, planners, service managers and epidemiological 
modellers to inform COVID-19 policy at the country level accross LMICs.  
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Main Table and Figures 
Table 1 Scenario Descriptions 
 
Scenario 1 Unmitigated epidemic 
Scenario 4 
 
The whole population is covered in this intervention scenario. The intervention is 
triggered by daily incidence reaching 1 per 10,000. The intervention includes self-
isolation of symptomatic persons for duration of symptoms, modelled as an 
additional reduction in contacts among symptomatic people of 75 %.The 
intervention includes distancing measures that reduce contacts at school by 20 
%.The intervention includes distancing measures that reduce contacts at work by 
20 %.The intervention includes distancing measures that reduce contacts in other 
settings by 20 %.The intervention includes distancing measures that reduce 
contacts in the home setting by 0%. There is no difference in intervention by age. 
Scenario 14 The whole population is covered in this intervention scenario. The intervention is 
triggered by daily incidence reaching 1 per 10,000. The intervention includes self-
isolation of symptomatic persons for duration of symptoms, modelled as an 
additional reduction in contacts among symptomatic people of 25 %.The 
intervention includes distancing measures that reduce contacts at school by 60 
%.The intervention includes distancing measures that reduce contacts at work by 
60 %.The intervention includes distancing measures that reduce contacts in other 
settings by 60 %.The intervention includes distancing measures that reduce 
contacts in the home setting by 0 %. There is no difference in intervention by age. 
Scenario 49 49.The intervention is temporary lockdown which leads to 100 % of the 
population reducing their contacts through school, home, work and other settings 
by 100 %, 0 %, 37.5 % and 37.5 % respectively for whilst in lockdown. Lockdown 
occurs for the first 30 days. After lockdown is lifted 100 % of the population 
reducing their contacts through school, home, work and other settings by 20 %, 0 
%, 20 % and 20 % respectively for whilst not in lockdown 
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1.a. Emergency Response Mechanisms: 
National level 
1,150.10  2,697.74  6,243.97  
1.b. Emergency Response Mechanisms: 
Training of health staff 
7,917.32  17,602.46  44,470.55  
2. Risk communication & community 
engagement 
101.44  240.58  551.17  
3.a. Case finding, contact tracing and 
management: Contact tracing 
2.93  9.84  19.24  
3.b. Case finding, contact tracing and 
management: Quarantine of contacts 
2.83  6.36  15.81  
4.a. Surveillance: Case notification 2.83  6.36  15.81  
4.b. Surveillance: Reporting (national level) 6.99  14.89  40.47  
5. Public health measures: Hygiene 
education 
61.29  145.82  333.91  
6. Screening and diagnosis 30.86  37.85  63.98  
7.a. Case Management: Home-based care 17.56  51.53  202.55  
7.b. Case Management: Hospital-based 
(severe case) 
34.74  42.68  136.44  
7.c. Case Management: Hospital-based 
(critical case) 
299.28  329.74  1,379.74  
7.d. Case Management: Death 64.52  64.52  64.52  
 
Table 3. Average Cost per Capita by Country Income Category (2019 US$) 
 Average Cost per Capita by Country Income Category 
(2019 US$) 
Scenario 1 Scenario 4 Scenario 14 Scenario 49 
Low Income Countries (LIC) 49.21  36.73  20.52  43.60  
Lower-Middle Income Countries 
(LMIC) 
61.14  45.96  27.34  54.98  
Upper-Middle Income Countries 
(UMIC) 
82.87  59.02  35.49  72.84  
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Table 4. Average % of Total Costs by Activity by Country Income Category by Scenario 
 
Scenario 1 Scenario 4 Scenario 14 Scenario 49 
LIC LMIC UMIC LIC LMIC UMIC LIC LMIC UMIC LIC LMIC UMIC 
1.a. Emergency Response 
Mechanisms: National level 
0.03% 0.01% 0.02% 0.04% 0.02% 0.02% 0.07% 0.03% 0.04% 0.03% 0.01% 0.02% 
1.b. Emergency Response 
Mechanisms: Training of health 
staff 
0.05% 0.12% 0.18% 0.07% 0.16% 0.27% 0.13% 0.27% 0.44% 0.06% 0.13% 0.21% 
2. Risk communication & 
community engagement 
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 
3.a. Case finding, contact tracing 
and management: Contact tracing 
0.96% 2.19% 1.24% 0.98% 2.27% 1.31% 0.96% 2.23% 1.25% 0.96% 2.22% 1.25% 
3.b. Case finding, contact tracing 
and management: Quarantine of 
contacts 
0.93% 1.17% 1.04% 0.95% 1.21% 1.10% 0.93% 1.17% 1.05% 0.93% 1.18% 1.06% 
4.a. Surveillance: Case notification 0.13% 0.17% 0.15% 0.14% 0.17% 0.16% 0.13% 0.17% 0.15% 0.13% 0.17% 0.15% 
4.b. Surveillance: Reporting 
(national level) 
0.00% 0.00% 0.01% 0.00% 0.01% 0.01% 0.01% 0.01% 0.02% 0.00% 0.01% 0.01% 
5. Public health measures: 
Hygiene education 
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 
6. Screening and diagnosis 58.42% 48.42% 25.10% 59.71% 50.07% 26.54% 58.25% 48.58% 25.26% 58.78% 48.91% 25.45% 
7.a. Case Management: Home-
based care 
1.19% 2.37% 2.56% 1.22% 2.45% 2.72% 1.19% 2.40% 2.59% 1.20% 2.39% 2.60% 
7.b. Case Management: Hospital-
based (severe case) 
6.65% 8.50% 10.72% 6.41% 8.14% 10.44% 6.67% 8.40% 10.67% 6.58% 8.39% 10.65% 
7.c. Case Management: Hospital-
based (critical case) 
31.23% 36.62% 58.79% 30.10% 35.10% 57.25% 31.26% 36.33% 58.34% 30.92% 36.16% 58.40% 
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Figure 1b. Total costs as a proportion of total health spending, including out-of-pocket payments 
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Supplemental Results Tables 
Table SR1. Unit costs per activity for base countries (2019 US$) 
Activity Unit Type 














1.b. Emergency Response Mechanisms: Training of 
health staff 







2. Risk communication & community engagement Per country per day 74.14  91.67  
1,133.4
4  
3.a. Case finding, contact tracing and management: 
Contact tracing 
Per person contacted 3.48  2.54  26.23  
3.b. Case finding, contact tracing and management: 
Quarantine of contacts 
Per person quarantined 1.72  2.35  29.22  
4.a. Surveillance: Case notification Per positive case 1.72  2.35  29.22  
4.b. Surveillance: Reporting (national level) Per country per week 3.69  6.52  68.26  
5. Public health measures: Hygiene education 
Per education campaign per 
month 
44.58  54.66  682.05  
6. Screening and diagnosis 
Per person screened and 
tested 
36.97  26.98  73.12  
7.a. Case Management: Home-based care 
Per person requiring home-
based care 
22.90  12.45  146.57  
7.b. Case Management: Hospital-based (severe case) 
Per day of hospitalisation 
(severe case) 
35.29  33.32  105.88  
7.c. Case Management: Hospital-based (critical case) 








7.d. Case Management: Death Per COVID-related death 64.52  64.52  64.52  
 
Table SR2: Cost per Capita by Country per Scenario (2019 US$) 
 
 Country Scenario 1 Scenario 4 Scenario 14 Scenario 49 
Afghanistan  $                                 42.91   $                                 31.69  
 $                       
17.89  
 $                       
37.66  
Algeria  $                               170.48   $                               113.61  
 $                       
59.33  
 $                       
144.09  
Angola  $                                 55.30   $                                 43.35  
 $                       
21.15  
 $                       
50.86  
Argentina  $                               381.86   $                               272.68  
 $                       
172.94  
 $                       
337.16  
Bangladesh  $                                 60.48   $                                 45.53  
 $                       
25.80  
 $                       
54.30  
Benin  $                                 53.05   $                                 40.34  
 $                       
21.95  
 $                       
47.44  
Bolivia  $                                 73.01   $                                 53.55  
 $                       
23.96  
 $                       
65.06  
Botswana  $                               186.86   $                               134.47  
 $                       
75.96  
 $                       
163.93  
Brazil  $                               272.86   $                               191.02  
 $                       
109.30  
 $                       
237.90  
Burkina Faso  $                                 47.56   $                                 36.44  
 $                       
21.13  
 $                       
42.53  
Burundi  $                                 36.54   $                                 27.25  
 $                       
14.96  
 $                       
32.19  
Cabo Verde  $                                 72.18   $                                 51.79  
 $                       
29.02  
 $                       
63.29  
Cambodia  $                                 49.37   $                                 34.85  
 $                       
14.09  
 $                       
42.52  
Cameroon  $                                 45.79   $                                 35.08  
 $                       
19.23  
 $                       
41.36  
Central African Republic  $                                 39.10   $                                 29.37  
 $                       
17.99  
 $                       
34.60  
Chad  $                                 42.57   $                                 30.45  
 $                       
15.46  
 $                       
36.92  
Colombia  $                               243.23   $                               170.71  
 $                       
95.34  
 $                       
212.16  
Comoros  $                                 47.50   $                                 35.66  
 $                       
19.64  
 $                       
42.39  
Congo, Dem. Rep.  $                                 41.27   $                                 30.99   $                        $                       
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15.05  36.49  
Congo, Rep.  $                                 52.39   $                                 40.41  
 $                       
24.93  
 $                       
47.65  
Costa Rica  $                               300.45   $                               208.46  
 $                       
121.44  
 $                       
261.18  
Cote d'Ivoire  $                                 47.48   $                                 35.51  
 $                       
16.05  
 $                       
42.28  
Cuba  $                               177.94   $                               124.79  
 $                       
74.54  
 $                       
155.92  
Djibouti  $                                 63.38   $                                 48.87  
 $                       
27.93  
 $                       
57.73  
Dominican Republic  $                               241.43   $                               172.09  
 $                       
100.59  
 $                       
212.38  
Ecuador  $                               192.89   $                               139.37  
 $                       
80.49  
 $                       
170.24  
Egypt, Arab Rep.  $                                 65.48   $                                 46.51  
 $                       
24.28  
 $                       
57.61  
El Salvador  $                                 92.14   $                                 67.64  
 $                       
38.64  
 $                       
82.62  
Equatorial Guinea  $                               176.53   $                               136.72  
 $                       
76.69  
 $                       
160.93  
Eswatini  $                                 65.63   $                                 49.31  
 $                       
23.26  
 $                       
59.24  
Ethiopia  $                                 69.49   $                                 51.53  
 $                       
28.21  
 $                       
61.19  
Gabon  $                               168.26   $                               126.68  
 $                       
80.05  
 $                       
151.45  
Gambia, The  $                                 52.29   $                                 39.81  
 $                       
22.82  
 $                       
46.54  
Ghana  $                                 54.47   $                                 41.05  
 $                       
18.71  
 $                       
48.84  
Guatemala  $                               118.41   $                                 86.00  
 $                       
49.53  
 $                       
104.09  
Guinea  $                                 54.11   $                                 41.04  
 $                       
22.89  
 $                       
48.41  
Guinea-Bissau  $                                 48.97   $                                 37.35  
 $                       
22.37  
 $                       
43.93  
Haiti  $                                 58.37   $                                 43.34  
 $                       
25.19  
 $                       
51.95  
Honduras  $                                 61.56   $                                 46.89  
 $                       
28.43  
 $                       
55.70  
India  $                                 93.33   $                                 70.12  
 $                       
42.75  
 $                       
84.06  
Iran, Islamic Rep.  $                                 89.86   $                                 60.68  
 $                       
34.65  
 $                       
76.81  
Iraq  $                               151.13   $                               112.54  
 $                       
62.28  
 $                       
134.73  
Jordan  $                               104.75   $                                 75.06  
 $                       
46.21  
 $                       
91.30  
Kenya  $                                 80.49   $                                 65.63  
 $                       
42.54  
 $                       
74.51  
Lebanon  $                               233.83   $                               170.83  
 $                       
115.21  
 $                       
207.94  
Lesotho  $                                 48.88   $                                 35.07  
 $                       
16.17  
 $                       
42.60  
Liberia  $                                 47.76   $                                 36.12  
 $                       
21.52  
 $                       
42.59  
Libya  $                               197.28   $                               137.16  
 $                       
72.53  
 $                       
170.74  
Madagascar  $                                 47.93   $                                 35.39  
 $                       
18.97  
 $                       
42.20  
Malawi  $                                 40.95   $                                 30.27  
 $                       
16.15  
 $                       
35.92  
Mali  $                                 45.49   $                                 32.63  
 $                       
16.59  
 $                       
39.60  
Mauritania  $                                 46.96   $                                 35.86  
 $                       
22.55  
 $                       
42.28  
Mauritius  $                               424.52   $                               293.12  
 $                       
185.65  
 $                       
367.56  
Morocco  $                                 90.69   $                                 67.48  
 $                       
42.16  
 $                       
81.61  
Mozambique  $                                 43.10   $                                 31.90  
 $                       
17.03  
 $                       
37.95  
Namibia  $                               107.73   $                                 79.92  
 $                       
37.34  
 $                       
95.34  
Nepal  $                                 73.35   $                                 54.18  
 $                       
27.55  
 $                       
65.05  
Nicaragua  $                                 59.49   $                                 44.13  
 $                       
24.50  
 $                       
52.93  
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Niger  $                                 37.52   $                                 26.71  
 $                       
13.53  
 $                       
32.35  
Nigeria  $                                 52.31   $                                 40.65  
 $                       
22.70  
 $                       
47.61  
Pakistan  $                                 44.49   $                                 32.37  
 $                       
18.38  
 $                       
38.84  
Paraguay  $                               173.69   $                               122.32  
 $                       
63.04  
 $                       
151.38  
Peru  $                               223.50   $                               155.85  
 $                       
79.73  
 $                       
193.43  
Rwanda  $                                 51.04   $                                 38.32  
 $                       
21.12  
 $                       
45.36  
Sao Tome and Principe  $                                 52.24   $                                 41.08  
 $                       
23.90  
 $                       
47.59  
Senegal  $                                 48.94   $                                 37.55  
 $                       
21.67  
 $                       
44.10  
Sierra Leone  $                                 46.26   $                                 35.06  
 $                       
20.91  
 $                       
41.31  
Somalia  $                                 34.07   $                                 25.41  
 $                       
13.44  
 $                       
29.90  
South Africa  $                               192.41   $                               144.25  
 $                       
85.86  
 $                       
174.88  
South Sudan  $                                 41.66   $                                 31.55  
 $                       
15.04  
 $                       
37.25  
Sri Lanka  $                               262.03   $                               187.59  
 $                       
121.06  
 $                       
230.21  
Sudan  $                                 46.53   $                                 35.05  
 $                       
19.11  
 $                       
41.44  
Syrian Arab Republic  $                                 51.82   $                                 40.43  
 $                       
24.75  
 $                       
47.54  
Tajikistan  $                                 56.95   $                                 40.38  
 $                       
20.72  
 $                       
49.42  
Tanzania  $                                 57.34   $                                 43.62  
 $                       
24.19  
 $                       
51.55  
Togo  $                                 47.51   $                                 36.17  
 $                       
19.77  
 $                       
42.43  
Tunisia  $                                 96.55   $                                 68.87  
 $                       
40.42  
 $                       
85.31  
Turkey  $                               396.71   $                               287.41  
 $                       
189.07  
 $                       
351.45  
Uganda  $                                 47.00   $                                 37.19  
 $                       
32.95  
 $                       
43.30  
Venezuela, RB  $                               151.61   $                               110.73  
 $                       
70.13  
 $                       
136.26  
West Bank and Gaza  $                                 56.41   $                                 42.82  
 $                       
26.25  
 $                       
51.07  
Yemen, Rep.  $                                 46.60   $                                 32.94  
 $                       
16.37  
 $                       
40.04  
Zambia  $                                 43.13   $                                 33.22  
 $                       
16.20  
 $                       
38.91  
Zimbabwe  $                                 52.44   $                                 42.80  
 $                       
40.49  
 $                       
49.55  
 
Table SR3. Total annual costs per country (2019 US$) 
Country  
Total Annual Costs per Country (2019 US$) 
Scenario 1 Scenario 4 Scenario 14 Scenario 49 
Afghanistan 1,595,006,688  1,177,904,724  664,951,614  1,399,789,895  
Algeria 7,198,927,335  4,797,609,340  2,505,281,318  6,084,882,367  
Angola 1,703,804,507  1,335,741,419  651,587,956  1,567,094,020  
Argentina 16,990,791,939  12,132,966,200  7,694,951,524  15,001,801,214  
Bangladesh 9,758,429,693  7,346,626,409  4,162,921,283  8,762,131,868  
Benin 609,231,361  463,323,321  252,112,394  544,803,973  
Bolivia 828,941,402  607,984,156  272,020,642  738,627,623  
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 25, 2020. ; https://doi.org/10.1101/2020.08.23.20180299doi: medRxiv preprint 
Botswana 421,205,098  303,116,161  171,230,132  369,522,644  
Brazil 57,156,312,626  40,013,304,222  22,894,275,352  49,832,168,384  
Burkina Faso 939,419,926  719,748,836  417,278,324  840,119,232  
Burundi 408,399,996  304,544,873  167,162,430  359,734,439  
Cabo Verde 39,247,227  28,162,920  15,780,012  34,414,567  
Cambodia 802,267,483  566,274,013  229,000,547  690,985,182  
Cameroon 1,154,599,786  884,467,637  484,883,954  1,043,034,826  
Central African Republic 182,433,804  137,035,951  83,939,501  161,434,468  
Chad 658,884,973  471,303,516  239,244,463  571,410,658  
Colombia 12,075,940,244  8,475,322,329  4,733,454,628  10,533,617,075  
Comoros 39,533,969  29,677,244  16,343,351  35,281,984  
Congo, Dem. Rep. 3,469,615,019  2,605,619,705  1,265,377,537  3,067,476,753  
Congo, Rep. 274,760,274  211,912,215  130,725,594  249,919,561  
Costa Rica 1,502,087,635  1,042,161,571  607,146,919  1,305,750,553  
Cote d'Ivoire 1,190,399,892  890,204,132  402,280,265  1,059,989,337  
Cuba 2,017,494,968  1,414,934,979  845,099,624  1,767,876,988  
Djibouti 60,775,939  46,862,116  26,784,302  55,355,583  
Dominican Republic 2,565,684,173  1,828,777,716  1,068,959,610  2,256,950,992  
Ecuador 3,295,395,303  2,380,985,925  1,375,043,118  2,908,422,164  
Egypt, Arab Rep. 6,445,190,291  4,577,530,923  2,389,669,661  5,670,659,187  
El Salvador 591,579,720  434,268,407  248,098,581  530,457,154  
Equatorial Guinea 231,075,219  178,959,540  100,391,379  210,653,340  
Eswatini 74,567,166  56,029,505  26,432,806  67,309,663  
Ethiopia 7,589,595,244  5,627,795,574  3,081,548,357  6,683,485,989  
Gabon 356,596,194  268,464,549  169,638,184  320,961,919  
Gambia, The 119,218,198  90,763,358  52,035,644  106,107,646  
Ghana 1,621,297,684  1,221,891,384  556,920,614  1,453,846,283  
Guatemala 2,042,320,674  1,483,251,542  854,210,602  1,795,402,698  
Guinea 671,793,449  509,527,263  284,208,408  600,953,264  
Guinea-Bissau 91,777,597  70,013,569  41,923,342  82,337,549  
Haiti 649,227,561  482,130,225  280,151,525  577,852,090  
Honduras 590,251,293  449,603,344  272,545,259  534,058,049  
India 126,241,607,727  94,845,714,832  57,820,205,064  113,697,199,394  
Iran, Islamic Rep. 7,350,914,852  4,963,443,606  2,834,585,552  6,283,486,292  
Iraq 5,808,461,053  4,325,177,524  2,393,641,505  5,178,286,305  
Jordan 1,042,846,812  747,309,105  460,019,255  908,958,207  
Kenya 4,136,465,948  3,372,960,785  2,186,416,908  3,829,322,849  
Lebanon 1,601,468,785  1,169,981,518  789,069,252  1,424,189,709  
Lesotho 103,041,897  73,935,288  34,089,165  89,815,951  
Liberia 230,138,172  174,077,339  103,699,634  205,216,814  
Libya 1,317,562,603  916,036,535  484,376,095  1,140,287,493  
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Madagascar 1,258,737,705  929,396,816  498,242,703  1,108,391,195  
Malawi 742,886,055  549,184,096  293,026,156  651,787,586  
Mali 867,812,732  622,492,840  316,411,256  755,421,554  
Mauritania 206,771,925  157,899,063  99,305,744  186,164,959  
Mauritius 537,143,681  370,884,267  234,900,728  465,076,712  
Mexico 34,115,201,144  24,625,827,163  15,782,810,293  30,216,622,750  
Morocco 3,267,515,013  2,431,152,726  1,519,075,135  2,940,380,785  
Mozambique 1,271,233,930  940,866,088  502,228,251  1,119,434,522  
Namibia 263,758,483  195,667,209  91,410,118  233,404,625  
Nepal 2,060,381,058  1,521,796,884  773,785,915  1,827,252,564  
Nicaragua 384,638,289  285,335,078  158,382,871  342,217,217  
Niger 842,039,860  599,341,108  303,663,836  725,945,647  
Nigeria 10,247,169,054  7,962,255,548  4,445,505,322  9,326,514,000  
Pakistan 9,441,146,849  6,868,761,344  3,901,350,552  8,242,469,426  
Paraguay 1,208,234,685  850,884,034  438,489,428  1,053,013,278  
Peru 7,149,625,157  4,985,660,537  2,550,356,751  6,187,688,798  
Rwanda 627,950,026  471,398,249  259,768,907  558,014,561  
Sao Tome and Principe 11,024,075  8,669,252  5,044,582  10,042,513  
Senegal 775,913,554  595,256,052  343,558,437  699,179,799  
Sierra Leone 353,894,747  268,216,325  159,990,783  316,044,465  
Somalia 511,309,434  381,354,484  201,668,843  448,722,521  
South Africa 11,117,131,659  8,334,446,288  4,960,920,248  10,104,268,308  
South Sudan 457,247,980  346,307,159  165,112,181  408,857,053  
Sri Lanka 5,678,100,834  4,065,040,082  2,623,300,200  4,988,596,480  
Sudan 1,944,960,100  1,465,299,051  798,971,465  1,732,370,209  
Syrian Arab Republic 876,059,081  683,467,982  418,397,444  803,740,032  
Tajikistan 518,284,390  367,451,171  188,545,177  449,773,206  
Tanzania 3,229,078,738  2,456,724,397  1,362,187,767  2,903,091,232  
Togo 374,774,447  285,340,906  155,932,903  334,768,272  
Tunisia 1,116,665,762  796,503,718  467,489,081  986,577,100  
Turkey 32,657,064,433  23,659,504,785  15,564,550,540  28,931,632,252  
Uganda 2,007,915,732  1,588,879,797  1,407,932,788  1,849,941,504  
Venezuela, RB 4,377,122,572  3,196,922,891  2,024,556,702  3,933,821,378  
West Bank and Gaza 257,722,952  195,636,416  119,932,408  233,328,972  
Yemen, Rep. 1,328,176,781  938,682,001  466,480,766  1,141,026,798  
Zambia 748,338,033  576,387,647  281,151,582  675,092,378  
Zimbabwe 757,131,633  617,966,425  584,680,182  715,488,782  
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Table SR4: Health System Costs of COVID 19 Response per capita as % of GDP per capita (nominal) 
Country Scenario 1 Scenario 4 Scenario 14 Scenario 49 
Afghanistan 8.24% 6.08% 3.43% 7.23% 
Algeria 4.14% 2.76% 1.44% 3.50% 
Angola 1.61% 1.26% 0.62% 1.48% 
Argentina 3.27% 2.33% 1.48% 2.89% 
Bangladesh 3.56% 2.68% 1.52% 3.20% 
Benin 5.88% 4.47% 2.43% 5.26% 
Bolivia 2.06% 1.51% 0.68% 1.83% 
Botswana 2.26% 1.63% 0.92% 1.98% 
Brazil 3.06% 2.14% 1.23% 2.67% 
Burkina Faso 6.65% 5.10% 2.95% 5.95% 
Burundi 13.45% 10.03% 5.50% 11.85% 
Cabo Verde 1.99% 1.42% 0.80% 1.74% 
Cambodia 3.27% 2.31% 0.93% 2.82% 
Cameroon 2.99% 2.29% 1.25% 2.70% 
Central African Republic 8.22% 6.17% 3.78% 7.27% 
Chad 5.84% 4.18% 2.12% 5.07% 
Colombia 3.65% 2.56% 1.43% 3.18% 
Comoros 3.36% 2.52% 1.39% 3.00% 
Congo, Dem. Rep. 7.35% 5.52% 2.68% 6.50% 
Congo, Rep. 2.44% 1.88% 1.16% 2.22% 
Costa Rica 2.50% 1.73% 1.01% 2.17% 
Cote d'Ivoire 2.77% 2.07% 0.94% 2.46% 
Cuba 2.02% 1.41% 0.84% 1.77% 
Djibouti 2.06% 1.59% 0.91% 1.87% 
Dominican Republic 3.00% 2.14% 1.25% 2.64% 
Ecuador 3.04% 2.20% 1.27% 2.68% 
Egypt, Arab Rep. 2.57% 1.82% 0.95% 2.26% 
El Salvador 2.27% 1.67% 0.95% 2.04% 
Equatorial Guinea 1.72% 1.33% 0.75% 1.57% 
Eswatini 1.58% 1.19% 0.56% 1.43% 
Ethiopia 9.00% 6.67% 3.65% 7.92% 
Gabon 2.12% 1.59% 1.01% 1.90% 
Gambia, The 7.30% 5.56% 3.19% 6.50% 
Ghana 2.47% 1.86% 0.85% 2.22% 
Guatemala 2.60% 1.89% 1.09% 2.29% 
Guinea 6.16% 4.67% 2.61% 5.51% 
Guinea-Bissau 6.29% 4.80% 2.88% 5.65% 
Haiti 6.72% 4.99% 2.90% 5.98% 
Honduras 2.46% 1.88% 1.14% 2.23% 
India 4.64% 3.49% 2.13% 4.18% 
Iran, Islamic Rep. 1.60% 1.08% 0.62% 1.36% 
Jordan 2.47% 1.77% 1.09% 2.15% 
Kenya 4.71% 3.84% 2.49% 4.36% 
Lebanon 2.83% 2.07% 1.39% 2.51% 
Lesotho 3.76% 2.70% 1.24% 3.28% 
Liberia 7.05% 5.33% 3.18% 6.29% 
Libya 2.72% 1.89% 1.00% 2.36% 
Madagascar 9.09% 6.71% 3.60% 8.00% 
Malawi 10.52% 7.77% 4.15% 9.23% 
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 25, 2020. ; https://doi.org/10.1101/2020.08.23.20180299doi: medRxiv preprint 
Mali 5.06% 3.63% 1.84% 4.40% 
Mauritania 3.95% 3.02% 1.90% 3.56% 
Mauritius 3.78% 2.61% 1.65% 3.27% 
Mexico 2.79% 2.02% 1.29% 2.48% 
Morocco 2.80% 2.08% 1.30% 2.52% 
Mozambique 8.64% 6.39% 3.41% 7.61% 
Namibia 1.82% 1.35% 0.63% 1.61% 
Nepal 7.09% 5.24% 2.66% 6.29% 
Nicaragua 2.93% 2.18% 1.21% 2.61% 
Niger 9.06% 6.45% 3.27% 7.81% 
Nigeria 2.58% 2.00% 1.12% 2.35% 
Pakistan 3.00% 2.18% 1.24% 2.62% 
Paraguay 2.98% 2.10% 1.08% 2.60% 
Peru 3.22% 2.25% 1.15% 2.79% 
Rwanda 6.60% 4.96% 2.73% 5.87% 
Sao Tome and Principe 2.61% 2.05% 1.19% 2.38% 
Senegal 3.22% 2.47% 1.42% 2.90% 
Sierra Leone 8.66% 6.57% 3.92% 7.74% 
South Africa 3.02% 2.26% 1.35% 2.74% 
Sri Lanka 6.39% 4.57% 2.95% 5.61% 
Sudan 4.76% 3.59% 1.96% 4.24% 
Syrian Arab Republic 2.55% 1.99% 1.22% 2.34% 
Tajikistan 6.89% 4.88% 2.51% 5.98% 
Tanzania 5.46% 4.15% 2.30% 4.91% 
Togo 6.99% 5.32% 2.91% 6.25% 
Tunisia 2.80% 2.00% 1.17% 2.47% 
Turkey 4.23% 3.07% 2.02% 3.75% 
Venezuela, RB 0.94% 0.69% 0.44% 0.85% 
Yemen, Rep. 4.93% 3.49% 1.73% 4.24% 
Zambia 2.80% 2.16% 1.05% 2.53% 
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Table SR5: Health System Costs of COVID 19 Response as % of total health spending (excl. OOP) 
Country Scenario 1 Scenario 4 Scenario 14 Scenario 49 
Afghanistan 74.95% 55.35% 31.25% 65.78% 
Algeria 65.46% 43.63% 22.78% 55.33% 
Angola 58.08% 45.53% 22.21% 53.42% 
Argentina 39.98% 28.55% 18.11% 35.30% 
Bangladesh 176.74% 133.06% 75.40% 158.70% 
Benin 174.48% 132.70% 72.20% 156.03% 
Bolivia 34.28% 25.14% 11.25% 30.54% 
Botswana 49.18% 35.39% 19.99% 43.15% 
Brazil 26.86% 18.80% 10.76% 23.42% 
Burkina Faso 116.17% 89.01% 51.60% 103.89% 
Burundi 197.95% 147.61% 81.02% 174.36% 
Cabo Verde 45.37% 32.56% 18.24% 39.79% 
Cambodia 63.56% 44.86% 18.14% 54.75% 
Cameroon 71.03% 54.41% 29.83% 64.16% 
Central African Republic 238.96% 179.50% 109.95% 211.46% 
Chad 134.35% 96.10% 48.78% 116.51% 
Colombia 71.46% 50.15% 28.01% 62.33% 
Comoros 80.51% 60.43% 33.28% 71.85% 
Congo, Dem. Rep. 201.15% 151.06% 73.36% 177.84% 
Congo, Rep. 74.44% 57.42% 35.42% 67.71% 
Costa Rica 33.80% 23.45% 13.66% 29.38% 
Cote d'Ivoire 70.27% 52.55% 23.75% 62.58% 
Cuba 18.33% 12.86% 7.68% 16.06% 
Djibouti 90.30% 69.62% 39.79% 82.24% 
Dominican Republic 58.29% 41.55% 24.29% 51.28% 
Ecuador 38.21% 27.61% 15.94% 33.73% 
Egypt, Arab Rep. 49.99% 35.51% 18.54% 43.99% 
El Salvador 31.35% 23.02% 13.15% 28.11% 
Equatorial Guinea 62.74% 48.59% 27.26% 57.19% 
Eswatini 29.75% 22.36% 10.55% 26.86% 
Ethiopia 252.46% 187.20% 102.50% 222.32% 
Gabon 76.36% 57.49% 36.33% 68.73% 
Gambia, The 249.81% 190.19% 109.04% 222.34% 
Ghana 80.68% 60.80% 27.71% 72.35% 
Guatemala 49.06% 35.63% 20.52% 43.13% 
Guinea 144.46% 109.57% 61.12% 129.23% 
Guinea-Bissau 125.38% 95.65% 57.27% 112.48% 
Haiti 154.72% 114.90% 66.77% 137.71% 
Honduras 30.85% 23.50% 14.25% 27.91% 
India 148.82% 111.81% 68.16% 134.03% 
Iran, Islamic Rep. 21.63% 14.61% 8.34% 18.49% 
Jordan 46.86% 33.58% 20.67% 40.84% 
Kenya 121.56% 99.13% 64.25% 112.54% 
Lebanon 35.31% 25.80% 17.40% 31.41% 
Lesotho 57.16% 41.01% 18.91% 49.82% 
Liberia 69.91% 52.88% 31.50% 62.34% 
Libya 63.11% 43.88% 23.20% 54.62% 
Madagascar 198.72% 146.73% 78.66% 174.98% 
Malawi 138.39% 102.30% 54.59% 121.42% 
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Mali 152.71% 109.54% 55.68% 132.94% 
Mauritania 100.40% 76.67% 48.22% 90.39% 
Mauritius 76.75% 53.00% 33.57% 66.46% 
Mexico 58.54% 42.26% 27.08% 51.85% 
Morocco 52.90% 39.36% 24.59% 47.60% 
Mozambique 224.38% 166.07% 88.65% 197.59% 
Namibia 26.75% 19.84% 9.27% 23.67% 
Nepal 161.39% 119.20% 60.61% 143.13% 
Nicaragua 31.62% 23.45% 13.02% 28.13% 
Niger 165.40% 117.73% 59.65% 142.60% 
Nigeria 65.94% 51.23% 28.61% 60.01% 
Pakistan 112.40% 81.78% 46.45% 98.13% 
Paraguay 53.08% 37.38% 19.26% 46.26% 
Peru 70.63% 49.25% 25.19% 61.13% 
Rwanda 106.17% 79.70% 43.92% 94.35% 
Sao Tome and Principe 49.69% 39.07% 22.74% 45.26% 
Senegal 93.02% 71.37% 41.19% 83.83% 
Sierra Leone 53.60% 40.62% 24.23% 47.87% 
South Africa 44.94% 33.69% 20.05% 40.84% 
Sri Lanka 171.15% 122.53% 79.07% 150.37% 
Sudan 30.61% 23.06% 12.57% 27.26% 
Syrian Arab Republic 78.34% 61.12% 37.42% 71.88% 
Tajikistan 102.25% 72.49% 37.20% 88.73% 
Tanzania 161.51% 122.88% 68.13% 145.21% 
Togo 122.53% 93.29% 50.98% 109.45% 
Tunisia 37.64% 26.85% 15.76% 33.26% 
Turkey 84.65% 61.33% 40.34% 74.99% 
Venezuela, RB 9.61% 7.02% 4.44% 8.63% 
Yemen, Rep. 64.69% 45.72% 22.72% 55.58% 
Zambia 76.27% 58.75% 28.66% 68.81% 
Zimbabwe 55.82% 45.56% 43.10% 52.75% 
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Table SR6: Health System Costs of COVID 19 Response as % of total health spending (incl. OOP) 
Country Scenario 1 Scenario 4 Scenario 14 Scenario 49 
Afghanistan 42.25% 31.20% 17.61% 37.08% 
Algeria 50.02% 33.33% 17.41% 42.28% 
Angola 42.95% 33.67% 16.43% 39.51% 
Argentina 34.52% 24.65% 15.64% 30.48% 
Bangladesh 102.82% 77.41% 43.86% 92.33% 
Benin 121.61% 92.48% 50.32% 108.75% 
Bolivia 26.77% 19.64% 8.79% 23.86% 
Botswana 46.73% 33.63% 19.00% 41.00% 
Brazil 18.71% 13.10% 7.49% 16.31% 
Burkina Faso 88.42% 67.74% 39.27% 79.07% 
Burundi 151.67% 113.10% 62.08% 133.59% 
Cabo Verde 36.01% 25.84% 14.48% 31.57% 
Cambodia 40.09% 28.30% 11.44% 34.53% 
Cameroon 41.90% 32.10% 17.60% 37.85% 
Central African Republic 167.01% 125.45% 76.84% 147.79% 
Chad 83.37% 59.63% 30.27% 72.30% 
Colombia 59.47% 41.74% 23.31% 51.88% 
Comoros 46.50% 34.91% 19.22% 41.50% 
Congo, Dem. Rep. 146.36% 109.92% 53.38% 129.40% 
Congo, Rep. 49.72% 38.35% 23.66% 45.23% 
Costa Rica 27.67% 19.20% 11.19% 24.06% 
Cote d'Ivoire 50.14% 37.50% 16.95% 44.65% 
Cuba 16.62% 11.66% 6.96% 14.56% 
Djibouti 71.80% 55.36% 31.64% 65.39% 
Dominican Republic 40.31% 28.73% 16.79% 35.46% 
Ecuador 27.20% 19.65% 11.35% 24.01% 
Egypt, Arab Rep. 30.86% 21.92% 11.44% 27.15% 
El Salvador 24.66% 18.10% 10.34% 22.11% 
Equatorial Guinea 36.30% 28.11% 15.77% 33.09% 
Eswatini 27.07% 20.34% 9.60% 24.44% 
Ethiopia 183.71% 136.22% 74.59% 161.78% 
Gabon 62.33% 46.92% 29.65% 56.10% 
Gambia, The 202.13% 153.88% 88.22% 179.90% 
Ghana 58.54% 44.12% 20.11% 52.49% 
Guatemala 32.00% 23.24% 13.38% 28.13% 
Guinea 96.46% 73.16% 40.81% 86.29% 
Guinea-Bissau 92.60% 70.64% 42.30% 83.07% 
Haiti 109.17% 81.07% 47.11% 97.17% 
Honduras 21.27% 16.21% 9.82% 19.25% 
India 90.42% 67.94% 41.42% 81.44% 
Iran, Islamic Rep. 15.59% 10.52% 6.01% 13.32% 
Jordan 36.61% 26.24% 16.15% 31.91% 
Kenya 95.18% 77.62% 50.31% 88.12% 
Lebanon 26.73% 19.52% 13.17% 23.77% 
Lesotho 48.08% 34.50% 15.90% 41.90% 
Liberia 47.47% 35.91% 21.39% 42.33% 
Libya 63.11% 43.88% 23.20% 54.62% 
Madagascar 162.41% 119.91% 64.29% 143.01% 
Malawi 124.24% 91.85% 49.01% 109.00% 
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Mali 112.89% 80.98% 41.16% 98.27% 
Mauritania 66.53% 50.81% 31.95% 59.90% 
Mauritius 51.80% 35.77% 22.65% 44.85% 
Mexico 41.70% 30.10% 19.29% 36.94% 
Morocco 35.59% 26.48% 16.55% 32.03% 
Mozambique 208.39% 154.24% 82.33% 183.51% 
Namibia 24.83% 18.42% 8.61% 21.97% 
Nepal 103.83% 76.69% 38.99% 92.08% 
Nicaragua 23.91% 17.74% 9.85% 21.27% 
Niger 104.35% 74.27% 37.63% 89.96% 
Nigeria 37.63% 29.24% 16.33% 34.25% 
Pakistan 68.03% 49.49% 28.11% 59.39% 
Paraguay 38.50% 27.12% 13.97% 33.56% 
Peru 55.06% 38.39% 19.64% 47.65% 
Rwanda 99.81% 74.92% 41.29% 88.69% 
Sao Tome and Principe 43.43% 34.16% 19.87% 39.57% 
Senegal 61.29% 47.02% 27.14% 55.23% 
Sierra Leone 37.86% 28.70% 17.12% 33.82% 
South Africa 41.70% 31.27% 18.61% 37.90% 
Sri Lanka 114.01% 81.62% 52.67% 100.16% 
Sudan 17.60% 13.26% 7.23% 15.68% 
Syrian Arab Republic 78.34% 61.12% 37.42% 71.88% 
Tajikistan 61.57% 43.65% 22.40% 53.43% 
Tanzania 132.50% 100.81% 55.90% 119.13% 
Togo 81.46% 62.02% 33.89% 72.76% 
Tunisia 26.91% 19.19% 11.26% 23.77% 
Turkey 72.68% 52.66% 34.64% 64.39% 
Venezuela, RB 9.61% 7.02% 4.44% 8.63% 
Yemen, Rep. 35.75% 25.27% 12.56% 30.71% 
Zambia 68.03% 52.40% 25.56% 61.37% 
Zimbabwe 46.04% 37.58% 35.55% 43.51% 
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Table SR7: Health System Costs of COVID 19 Response as % of government health spending 
Country Scenario 1 Scenario 4 Scenario 14 Scenario 49 
Afghanistan 1461.58% 1079.37% 609.33% 1282.69% 
Algeria 96.72% 81.75% 33.66% 81.75% 
Angola 131.58% 121.02% 50.32% 121.02% 
Argentina 53.71% 47.42% 24.33% 47.42% 
Bangladesh 984.27% 883.78% 419.89% 883.78% 
Benin 849.59% 759.74% 351.58% 759.74% 
Bolivia 52.17% 46.49% 17.12% 46.49% 
Botswana 87.93% 77.14% 35.75% 77.14% 
Brazil 80.84% 70.48% 32.38% 70.48% 
Burkina Faso 289.72% 259.10% 128.69% 259.10% 
Burundi 679.59% 598.61% 278.16% 598.61% 
Cabo Verde 79.91% 70.07% 32.13% 70.07% 
Cambodia 291.48% 251.05% 83.20% 251.05% 
Cameroon 532.62% 481.16% 223.68% 481.16% 
Central African Republic 1607.91% 1422.83% 739.81% 1422.83% 
Chad 712.01% 617.48% 258.53% 617.48% 
Colombia 112.68% 98.29% 44.17% 98.29% 
Comoros 553.08% 493.60% 228.65% 493.60% 
Congo, Dem. Rep. 1641.60% 1451.34% 598.70% 1451.34% 
Congo, Rep. 176.09% 160.17% 83.78% 160.17% 
Costa Rica 45.22% 39.31% 18.28% 39.31% 
Cote d'Ivoire 272.68% 242.80% 92.15% 242.80% 
Cuba 20.46% 17.93% 8.57% 17.93% 
Djibouti 197.29% 179.69% 86.95% 179.69% 
Dominican Republic 127.48% 112.14% 53.11% 112.14% 
Ecuador 74.65% 65.88% 31.15% 65.88% 
Egypt, Arab Rep. 170.63% 150.12% 63.26% 150.12% 
El Salvador 48.63% 43.61% 20.40% 43.61% 
Equatorial Guinea 266.82% 243.24% 115.92% 243.24% 
Eswatini 42.93% 38.75% 15.22% 38.75% 
Ethiopia 914.16% 805.02% 371.17% 805.02% 
Gabon 118.23% 106.41% 56.24% 106.41% 
Gambia, The 1345.47% 1197.51% 587.26% 1197.51% 
Ghana 210.35% 188.62% 72.25% 188.62% 
Guatemala 131.83% 115.89% 55.14% 115.89% 
Guinea 1174.62% 1050.76% 496.94% 1050.76% 
Guinea-Bissau 283.34% 254.19% 129.43% 254.19% 
Haiti 1008.94% 898.02% 435.37% 898.02% 
Honduras 67.20% 60.80% 31.03% 60.80% 
India 585.28% 527.12% 268.06% 527.12% 
Iran, Islamic Rep. 39.68% 33.91% 15.30% 33.91% 
Jordan 74.11% 64.60% 32.69% 64.60% 
Kenya 336.03% 311.08% 177.61% 311.08% 
Lebanon 67.74% 60.24% 33.38% 60.24% 
Lesotho 89.58% 78.08% 29.63% 78.08% 
Liberia 490.72% 437.58% 221.12% 437.58% 
Libya 99.72% 86.30% 36.66% 86.30% 
Madagascar 417.01% 367.20% 165.06% 367.20% 
Malawi 493.40% 432.89% 194.62% 432.89% 
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Mali 483.29% 420.70% 176.21% 420.70% 
Mauritania 273.93% 246.63% 131.56% 246.63% 
Mauritius 173.99% 150.65% 76.09% 150.65% 
Mexico 112.26% 99.44% 51.94% 99.44% 
Morocco 112.89% 101.59% 52.48% 101.59% 
Mozambique 420.65% 370.42% 166.19% 370.42% 
Namibia 43.22% 38.24% 14.98% 38.24% 
Nepal 868.62% 770.34% 326.22% 770.34% 
Nicaragua 51.54% 45.85% 21.22% 45.85% 
Niger 680.99% 587.10% 245.58% 587.10% 
Nigeria 506.26% 460.77% 219.63% 460.77% 
Pakistan 402.92% 351.76% 166.50% 351.76% 
Paraguay 102.82% 89.61% 37.32% 89.61% 
Peru 110.23% 95.40% 39.32% 95.40% 
Rwanda 313.36% 278.46% 129.63% 278.46% 
Sao Tome and Principe 124.55% 113.46% 56.99% 113.46% 
Senegal 269.12% 242.51% 119.16% 242.51% 
Sierra Leone 479.73% 428.42% 216.88% 428.42% 
South Africa 83.63% 76.01% 37.32% 76.01% 
Sri Lanka 397.17% 348.94% 183.49% 348.94% 
Sudan 157.07% 139.90% 64.52% 139.90% 
Syrian Arab Republic 173.02% 158.74% 82.63% 158.74% 
Tajikistan 357.52% 310.26% 130.06% 310.26% 
Tanzania 397.58% 357.44% 167.72% 357.44% 
Togo 611.16% 545.92% 254.28% 545.92% 
Tunisia 66.46% 58.72% 27.83% 58.72% 
Turkey 107.91% 95.60% 51.43% 95.60% 
Venezuela, RB 25.19% 22.64% 11.65% 22.64% 
Yemen, Rep. 635.34% 545.82% 223.14% 545.82% 
Zambia 199.20% 179.70% 74.84% 179.70% 
Zimbabwe 120.03% 113.43% 92.69% 113.43% 
 
Table SR8. Average Cost per Capita by Country Income Category (2019 US$): Sensitivity Analysis on % of symptomatic cases tested  
  Scenario 1 Scenario 4 Scenario 14 Scenario 49 
Average Cost per Capita by Country Income Category (2019 US$): 20% of Symptomatic Cases Tested 
Low Income Countries (LIC) 49.81  37.18  20.77  44.12  
Lower-Middle Income Countries (LMIC) 62.64  47.09  28.00  56.30  
Upper-Middle Income Countries (UMIC) 85.05  60.62  36.41  74.74  
Average Cost per Capita by Country Income Category (2019 US$): 40% of Symptomatic Cases Tested 
Low Income Countries (LIC) 51.00  38.07  21.26   45.16  
Lower-Middle Income Countries (LMIC) 65.63  49.34  29.31   58.93  
Upper-Middle Income Countries (UMIC) 89.40  63.83  38.25   78.53  
Average Cost per Capita by Country Income Category (2019 US$): 60% of Symptomatic Cases Tested 
Low Income Countries (LIC) 52.19  38.97  21.74  46.21  
Lower-Middle Income Countries (LMIC) 68.63  51.59  30.63  61.56  
Upper-Middle Income Countries (UMIC) 93.74  67.03  40.09  82.32  
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Average Cost per Capita by Country Income Category (2019 US$): 80% of Symptomatic Cases Tested 
Low Income Countries (LIC) 53.39  39.86  22.23  47.25  
Lower-Middle Income Countries (LMIC) 71.62  53.85  31.94  64.19  
Upper-Middle Income Countries (UMIC) 98.09  70.24  41.93  86.11  
Average Cost per Capita by Country Income Category (2019 US$): 100% of Symptomatic Cases Tested 
Low Income Countries (LIC) 54.58  40.75  22.72  48.30  
Lower-Middle Income Countries (LMIC) 74.62  56.10  33.25  66.82  
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Supplement S1. Epidemiological model  
 
S1.1 Parameters used in epidemiological model 
 








Description Value Reference 




  Duration of preclinical infectiousness 




   Duration of clinical infectiousness (IC 




  Duration of subclinical infectiousness 




 Incubation period (E to IC; days)      ; mean 6.4 days Derived 
 Serial interval (days)          
1   /2; mean 
approximately 7 days 
Derived 

 Susceptibility to infection on contact Calculated from R0 Derived 
  Probability of clinical symptoms on 
infection for age group i 
Estimated from case 




 Relative infectiousness of subclinical 
cases 
50% Assumed 
  Number of age-j individuals 
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day 
 Number of age-i individuals Demographic data 
5
 
 Time step for discrete-time 
simulation 
0.25 days  





 Duration of hospitalisation in non-ICU 





 Duration of hospitalisation in non-ICU 





 Duration of hospitalisation in ICU 














Age group Case-fatality risk % of cases hospitalised % of hospital patients needing ICU 
0–9 0.00% 0.0% 30% 
1–10 0.09% 0.8% 30% 
20-29 0.10% 0.8% 30% 
30-39 0.12% 1.0% 30% 
40-49 0.23% 1.9% 30% 
50-59 0.68% 5.4% 30% 
60-69 1.87% 15.1% 30% 
70-79 4.14% 33.3% 30% 




The epidemiological model uses data from 92 low- and middle-income countries. For each country, 
the model produces estimates on the number of cases, hospitalisations, number of days in hospital 
for severe cases (general ward) and critical cases (intensive care unit), and deaths for 57 distinct 
epidemiological scenarios [16]. 
For this study, four epidemiological scenarios were chosen out of the set of 57 possible scenarios. 
Scenario 1 represents an unmitigated epidemic. The other three scenarios were chosen because 
they represent a variety of plausible policy options (scenarios 4,14 and 49). Descriptions of the 
scenarios are presented below. 
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Table S1.2.1 Scenario Descriptions 
 
Scenario 1 Unmitigated epidemic 
Scenario 4 
 
The whole population is covered in this intervention scenario. The intervention is 
triggered by daily incidence reaching 1 per 10,000. The intervention includes self-
isolation of symptomatic persons for duration of symptoms, modelled as an 
additional reduction in contacts among symptomatic people of 75 %.The 
intervention includes distancing measures that reduce contacts at school by 20 
%.The intervention includes distancing measures that reduce contacts at work by 
20 %.The intervention includes distancing measures that reduce contacts in other 
settings by 20 %.The intervention includes distancing measures that reduce 
contacts in the home setting by 0%. There is no difference in intervention by age. 
Scenario 14 The whole population is covered in this intervention scenario. The intervention is 
triggered by daily incidence reaching 1 per 10,000. The intervention includes self-
isolation of symptomatic persons for duration of symptoms, modelled as an 
additional reduction in contacts among symptomatic people of 25 %.The 
intervention includes distancing measures that reduce contacts at school by 60 
%.The intervention includes distancing measures that reduce contacts at work by 
60 %.The intervention includes distancing measures that reduce contacts in other 
settings by 60 %.The intervention includes distancing measures that reduce 
contacts in the home setting by 0 %. There is no difference in intervention by age. 
Scenario 49 49.The intervention is temporary lockdown which leads to 100 % of the 
population reducing their contacts through school, home, work and other settings 
by 100 %, 0 %, 37.5 % and 37.5 % respectively for whilst in lockdown. Lockdown 
occurs for the first 30 days. After lockdown is lifted 100 % of the population 
reducing their contacts through school, home, work and other settings by 20 %, 0 
%, 20 % and 20 % respectively for whilst not in lockdown 
 
S1.3 The number of cases  
 
The total number of expected cases, deaths, and days of hospitalisation in ICU and general ward per 
country per scenario used in this study are in the table below [16].  
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Table S1.3.1 Number of cases, deaths, and days of hospitalisation per country per scenario 
 
Country Scenario 
Total Number of 
Cases 
Total Number of 
ICU bed days 
Total Number of 
Non-ICU Bed Days 
Total Number of 
Deaths 
Afghanistan 1 12,218,383.50 1,644,757.00 3,068,969.00 102,556.50 
Afghanistan 4 9,128,640.00 1,124,521.50 2,096,065.00 69,979.50 
Afghanistan 14 5,057,916.50 659,168.00 1,228,499.50 40,910.50 
Afghanistan 49 10,687,758.50 1,379,971.50 2,571,195.50 85,767.00 
Angola 1 10,568,601.50 1,337,285.50 2,495,053.00 82,996.50 
Angola 4 7,951,658.50 958,470.50 1,790,227.00 59,579.00 
Angola 14 3,787,000.00 480,525.00 904,767.50 29,918.00 
Angola 49 9,243,635.50 1,153,108.50 2,151,983.50 71,542.50 
United Arab Emirates 1 3,070,769.50 350,542.50 651,357.50 21,779.50 
United Arab Emirates 4 2,177,762.50 214,356.00 402,281.50 13,375.50 
United Arab Emirates 14 1,024,344.50 89,813.50 167,419.00 5,562.50 
United Arab Emirates 49 2,602,624.00 273,597.50 513,621.00 17,056.00 
Argentina 1 16,773,844.50 7,129,191.50 13,331,842.50 443,779.00 
Argentina 4 12,167,825.00 4,923,903.50 9,183,093.00 306,424.50 
Argentina 14 7,206,744.00 3,179,286.50 5,930,434.50 197,212.00 
Argentina 49 14,559,346.00 6,161,078.00 11,508,389.50 383,318.00 
Burundi 1 3,825,576.00 487,746.00 912,820.50 30,294.00 
Burundi 4 2,875,191.50 343,198.50 643,374.00 21,457.50 
Burundi 14 1,563,193.50 192,616.50 359,761.00 11,941.00 
Burundi 49 3,360,357.50 416,410.00 783,449.00 25,958.50 
Benin 1 3,987,007.50 610,334.00 1,140,852.50 37,966.50 
Benin 4 3,027,030.50 436,070.50 813,543.50 27,098.50 
Benin 14 1,617,554.00 243,858.00 455,765.00 15,180.50 
Benin 49 3,517,493.00 523,439.50 980,737.50 32,600.50 
Burkina Faso 1 6,855,948.00 954,394.50 1,781,199.00 59,384.50 
Burkina Faso 4 5,231,105.00 692,106.50 1,290,564.50 42,964.50 
Burkina Faso 14 2,954,321.00 421,062.50 787,440.50 26,089.50 
Burkina Faso 49 6,035,205.50 826,512.00 1,546,412.50 51,439.50 
Bangladesh 1 57,227,126.50 14,236,787.50 26,575,364.00 885,268.50 
Bangladesh 4 43,270,144.00 10,038,443.00 18,753,926.00 623,994.50 
Bangladesh 14 23,696,468.50 5,910,527.00 11,038,186.50 366,350.50 
Bangladesh 49 50,407,176.00 12,324,088.50 23,001,526.50 766,395.00 
Bahrain 1 547,191.50 80,485.50 150,131.00 5,024.50 
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Bahrain 4 391,589.50 50,957.50 94,643.50 3,172.50 
Bahrain 14 197,184.50 23,694.50 43,975.00 1,460.00 
Bahrain 49 468,646.00 64,898.00 121,082.00 3,992.00 
Bolivia 1 3,881,885.00 929,770.50 1,734,888.50 57,656.00 
Bolivia 4 2,855,102.00 614,416.00 1,146,287.00 38,054.00 
Bolivia 14 1,246,487.00 279,998.50 519,996.50 17,368.00 
Bolivia 49 3,364,052.00 778,136.00 1,449,732.50 48,330.00 
Brazil 1 76,815,441.00 27,418,042.50 51,183,618.50 1,705,997.00 
Brazil 4 56,285,085.00 18,283,101.50 34,119,544.00 1,139,191.50 
Brazil 14 30,752,013.00 10,628,491.00 19,851,592.50 658,619.00 
Brazil 49 66,729,481.50 23,242,138.50 43,395,705.00 1,445,675.00 
Botswana 1 765,573.00 159,460.50 296,628.50 9,918.00 
Botswana 4 565,035.50 107,208.00 199,542.00 6,659.50 
Botswana 14 305,081.50 61,841.00 114,201.00 3,788.50 
Botswana 49 662,701.50 134,417.50 250,989.00 8,333.50 
Central African Republic 1 1,542,576.00 227,256.00 422,653.00 14,107.50 
Central African Republic 4 1,168,850.50 158,951.50 297,690.50 9,899.50 
Central African Republic 14 696,606.50 102,635.00 192,340.00 6,435.00 
Central African Republic 49 1,353,904.00 194,598.50 363,300.50 12,130.00 
Chile 1 7,194,690.00 3,077,838.50 5,737,576.50 191,424.00 
Chile 4 5,194,730.50 2,043,884.50 3,820,076.00 126,898.00 
Chile 14 3,037,288.00 1,252,044.50 2,330,419.00 77,706.50 
Chile 49 6,244,492.50 2,596,331.50 4,850,755.50 161,525.00 
Cote d'Ivoire 1 8,535,011.50 1,316,578.00 2,457,105.50 82,052.50 
Cote d'Ivoire 4 6,298,091.50 916,128.00 1,708,562.00 57,155.50 
Cote d'Ivoire 14 2,781,975.00 429,891.00 803,017.00 26,661.00 
Cote d'Ivoire 49 7,403,108.50 1,119,330.00 2,085,969.00 69,716.00 
Cameroon 1 8,729,175.00 1,249,335.00 2,335,084.00 77,781.00 
Cameroon 4 6,604,562.00 889,631.00 1,661,757.00 55,432.00 
Cameroon 14 3,552,194.00 503,335.50 939,579.50 31,264.50 
Cameroon 49 7,690,769.50 1,078,672.50 2,014,896.00 67,062.00 
Congo, Dem. Rep. 1 28,914,534.50 4,131,602.50 7,713,653.50 257,149.00 
Congo, Dem. Rep. 4 21,729,089.00 2,925,815.50 5,459,743.00 181,724.50 
Congo, Dem. Rep. 14 10,339,604.50 1,480,493.00 2,755,736.00 91,222.50 
Congo, Dem. Rep. 49 25,274,207.00 3,537,679.50 6,601,660.50 219,628.00 
Congo, Rep. 1 1,819,209.50 284,222.00 531,531.00 17,714.00 
Congo, Rep. 4 1,380,686.00 201,095.00 376,298.50 12,564.00 
Congo, Rep. 14 828,849.00 128,923.50 241,162.00 8,084.50 
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Congo, Rep. 49 1,603,300.00 245,240.00 457,933.50 15,290.00 
Colombia 1 18,341,207.00 6,156,013.50 11,493,003.50 382,744.50 
Colombia 4 13,426,478.00 4,130,466.00 7,696,118.00 256,667.50 
Colombia 14 7,192,837.50 2,342,406.50 4,372,127.00 144,932.50 
Colombia 49 15,964,752.50 5,231,315.00 9,754,859.00 325,054.00 
Comoros 1 290,557.00 47,011.00 87,852.50 2,911.50 
Comoros 4 215,334.50 32,916.00 61,230.50 2,047.00 
Comoros 14 114,051.50 18,550.50 34,354.00 1,129.00 
Comoros 49 252,887.00 40,321.50 75,628.00 2,512.00 
Cabo Verde 1 181,545.00 41,378.50 77,437.00 2,565.50 
Cabo Verde 4 128,006.00 26,548.00 49,137.00 1,638.00 
Cabo Verde 14 67,260.50 14,657.00 27,550.00 904.50 
Cabo Verde 49 153,456.00 33,984.50 63,202.50 2,102.00 
Costa Rica 1 1,822,572.50 652,845.00 1,218,193.50 40,619.00 
Costa Rica 4 1,326,970.50 428,626.50 799,723.50 26,658.50 
Costa Rica 14 745,696.00 252,692.50 470,210.00 15,640.50 
Costa Rica 49 1,578,679.00 549,464.00 1,023,618.50 34,173.50 
Cuba 1 4,423,054.50 2,120,624.00 3,955,835.50 131,915.50 
Cuba 4 3,216,773.00 1,414,337.00 2,640,812.00 87,972.00 
Cuba 14 1,810,327.00 857,054.50 1,601,201.00 53,185.50 
Cuba 49 3,831,103.00 1,804,660.00 3,363,770.00 111,899.50 
Djibouti 1 343,723.00 73,381.50 136,983.50 4,544.00 
Djibouti 4 261,053.50 51,856.50 97,124.00 3,227.50 
Djibouti 14 142,168.00 30,426.50 55,879.50 1,876.50 
Djibouti 49 302,937.00 63,302.00 118,347.50 3,926.00 
Dominican Republic 1 3,807,776.50 1,127,809.00 2,105,556.50 70,140.00 
Dominican Republic 4 2,808,434.50 765,172.00 1,422,811.50 47,526.00 
Dominican Republic 14 1,562,725.00 456,252.50 850,089.00 28,342.50 
Dominican Republic 49 3,315,475.00 964,871.00 1,796,265.00 59,882.00 
Algeria 1 14,034,752.50 3,466,814.50 6,462,517.50 215,452.50 
Algeria 4 9,901,969.50 2,171,943.50 4,050,558.50 135,157.00 
Algeria 14 5,054,134.00 1,144,758.00 2,139,220.50 70,839.50 
Algeria 49 11,937,307.00 2,835,057.50 5,295,541.50 175,988.50 
Ecuador 1 6,238,253.50 1,828,486.50 3,416,054.50 113,769.50 
Ecuador 4 4,681,265.50 1,256,086.50 2,337,135.50 77,960.00 
Ecuador 14 2,586,022.00 739,506.00 1,376,652.00 45,789.00 
Ecuador 49 5,480,200.00 1,567,059.00 2,923,489.50 97,213.50 
Egypt, Arab Rep. 1 32,689,306.00 7,149,997.50 13,352,307.50 444,818.00 
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Egypt, Arab Rep. 4 23,251,249.50 4,594,336.00 8,576,020.00 285,393.00 
Egypt, Arab Rep. 14 11,840,378.50 2,461,238.50 4,607,142.50 152,674.00 
Egypt, Arab Rep. 49 27,975,740.50 5,946,558.50 11,123,014.50 370,198.00 
Eritrea 1 1,155,784.50 209,554.50 391,035.00 13,020.50 
Eritrea 4 871,719.50 146,793.00 273,048.00 9,126.00 
Eritrea 14 463,730.00 85,068.00 156,997.50 5,297.00 
Eritrea 49 1,011,765.50 180,018.50 336,576.50 11,223.50 
Ethiopia 1 37,424,354.50 6,123,829.50 11,438,760.00 380,821.00 
Ethiopia 4 28,272,226.50 4,318,604.50 8,066,304.00 268,718.00 
Ethiopia 14 14,996,879.50 2,457,011.50 4,593,451.50 152,670.50 
Ethiopia 49 32,804,209.50 5,277,772.50 9,861,570.50 328,539.50 
Gabon 1 752,439.50 127,913.00 239,230.50 7,959.50 
Gabon 4 572,425.50 89,835.00 168,146.00 5,614.00 
Gabon 14 347,308.00 58,094.50 109,709.00 3,636.00 
Gabon 49 664,127.50 110,378.00 206,161.50 6,867.50 
Ghana 1 10,378,959.00 1,826,469.00 3,406,631.50 113,607.50 
Ghana 4 7,713,893.50 1,273,479.00 2,379,059.00 79,389.50 
Ghana 14 3,423,372.00 602,269.50 1,120,060.00 37,243.50 
Ghana 49 9,039,576.00 1,557,543.50 2,901,100.00 96,752.50 
Guinea 1 4,258,486.00 700,272.50 1,311,263.50 43,626.50 
Guinea 4 3,197,000.00 509,156.50 950,868.50 31,664.00 
Guinea 14 1,702,114.50 304,197.50 565,934.00 18,715.50 
Guinea 49 3,718,928.00 614,330.50 1,144,140.00 38,187.50 
Gambia, The 1 787,667.00 120,449.50 224,341.50 7,490.50 
Gambia, The 4 592,870.50 88,337.00 163,947.00 5,442.50 
Gambia, The 14 324,941.50 53,736.50 101,076.00 3,349.50 
Gambia, The 49 686,599.00 104,927.00 196,707.00 6,559.00 
Guinea-Bissau 1 646,616.00 100,305.50 186,821.00 6,207.50 
Guinea-Bissau 4 490,671.00 72,272.00 135,491.00 4,505.50 
Guinea-Bissau 14 284,320.50 45,433.50 83,768.50 2,782.00 
Guinea-Bissau 49 569,959.50 87,200.50 163,160.00 5,405.50 
Equatorial Guinea 1 471,118.00 62,021.00 116,073.50 3,858.00 
Equatorial Guinea 4 359,112.50 44,812.00 83,461.50 2,771.50 
Equatorial Guinea 14 194,873.50 25,338.00 47,642.00 1,593.50 
Equatorial Guinea 49 416,196.50 53,836.00 100,579.00 3,348.50 
Guatemala 1 5,931,816.00 1,188,377.50 2,215,138.50 73,895.00 
Guatemala 4 4,445,955.00 809,410.50 1,509,951.00 50,397.50 
Guatemala 14 2,471,211.50 477,647.50 888,300.00 29,575.50 
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Guatemala 49 5,200,461.00 1,004,988.50 1,873,662.50 62,445.50 
Honduras 1 3,368,666.00 711,831.50 1,328,438.50 44,068.00 
Honduras 4 2,554,279.00 498,194.50 928,828.50 30,884.00 
Honduras 14 1,508,914.50 311,765.50 579,275.50 19,367.50 
Honduras 49 2,966,095.00 611,292.00 1,145,329.00 38,068.50 
Haiti 1 3,844,733.00 864,007.50 1,611,689.00 53,684.00 
Haiti 4 2,891,883.50 602,645.50 1,127,804.50 37,538.50 
Haiti 14 1,628,745.00 363,202.00 678,225.00 22,680.00 
Haiti 49 3,378,437.50 746,954.00 1,392,144.50 46,506.50 
India 1 485,771,554.00 134,139,960.00 250,304,012.50 8,338,437.50 
India 4 365,933,321.50 93,048,830.00 173,656,181.50 5,785,606.50 
India 14 217,279,232.00 58,353,362.00 108,949,367.00 3,620,179.00 
India 49 427,295,820.50 115,025,840.50 214,808,061.50 7,154,678.00 
Iran, Islamic Rep. 1 27,824,797.00 7,261,103.00 13,561,427.50 451,739.50 
Iran, Islamic Rep. 4 19,593,066.00 4,553,642.50 8,499,919.50 282,846.00 
Iran, Islamic Rep. 14 11,174,742.50 2,592,113.50 4,837,163.50 161,457.50 
Iran, Islamic Rep. 49 23,673,028.50 5,957,133.50 11,119,019.00 370,270.00 
Iraq 1 13,378,016.00 2,160,705.50 4,036,576.50 134,703.50 
Iraq 4 10,055,987.00 1,513,885.00 2,832,294.00 94,396.50 
Iraq 14 5,444,675.50 850,809.00 1,586,860.50 52,768.00 
Iraq 49 11,745,266.50 1,852,021.00 3,459,984.50 115,381.50 
Israel 1 3,220,231.50 1,398,523.50 2,612,412.50 86,885.00 
Israel 4 2,318,309.00 960,045.00 1,794,150.50 59,726.50 
Israel 14 1,417,351.00 644,261.00 1,206,315.50 39,883.00 
Israel 49 2,790,877.00 1,206,535.00 2,251,874.50 74,860.00 
Jordan 1 3,230,120.50 545,182.00 1,014,537.00 33,793.00 
Jordan 4 2,403,684.50 360,587.00 671,528.00 22,395.50 
Jordan 14 1,441,001.50 226,240.50 421,434.00 14,019.50 
Jordan 49 2,802,081.50 455,065.50 851,418.00 28,348.50 
Kenya 1 17,932,717.50 3,334,486.00 6,220,435.00 207,231.00 
Kenya 4 13,972,380.00 2,685,062.50 5,015,623.00 166,727.00 
Kenya 14 8,920,886.50 1,777,160.50 3,304,638.00 110,213.50 
Kenya 49 15,940,230.00 3,027,794.00 5,654,038.00 188,428.00 
Cambodia 1 5,249,630.00 1,075,358.00 2,009,206.50 67,003.00 
Cambodia 4 3,735,696.50 699,366.00 1,307,951.50 43,432.50 
Cambodia 14 1,491,662.00 285,706.00 532,484.00 17,649.50 
Cambodia 49 4,455,701.50 883,329.50 1,656,497.50 55,016.50 
Kuwait 1 1,365,100.50 250,497.00 468,191.50 15,520.50 
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Kuwait 4 927,501.50 153,854.00 289,037.50 9,618.00 
Kuwait 14 463,836.00 72,077.00 134,599.00 4,499.00 
Kuwait 49 1,135,226.00 198,574.50 372,262.50 12,352.50 
Lebanon 1 2,473,141.50 849,633.00 1,578,978.00 52,778.00 
Lebanon 4 1,838,520.50 596,389.00 1,111,151.00 36,992.00 
Lebanon 14 1,166,531.50 410,943.00 767,150.00 25,627.50 
Lebanon 49 2,165,967.50 736,594.00 1,374,880.00 45,888.00 
Liberia 1 1,679,614.00 288,953.00 537,754.50 17,919.00 
Liberia 4 1,277,408.00 204,826.00 383,901.50 12,778.00 
Liberia 14 740,784.00 127,259.00 237,192.00 7,905.00 
Liberia 49 1,478,591.00 249,999.00 464,731.00 15,427.50 
Libya 1 2,278,126.50 480,466.00 897,001.00 29,872.50 
Libya 4 1,632,674.50 312,685.50 585,736.00 19,495.50 
Libya 14 836,827.00 167,080.50 312,036.00 10,330.00 
Libya 49 1,947,756.50 401,240.50 748,905.50 24,938.00 
Sri Lanka 1 8,020,343.00 3,408,469.50 6,355,545.00 211,681.00 
Sri Lanka 4 5,916,153.00 2,373,553.00 4,436,366.50 147,651.50 
Sri Lanka 14 3,594,781.50 1,558,313.00 2,903,474.50 96,594.00 
Sri Lanka 49 7,016,699.00 2,945,770.00 5,508,073.00 183,971.50 
Lesotho 1 696,741.00 145,159.00 271,320.50 9,016.50 
Lesotho 4 508,495.00 95,194.00 178,041.00 5,963.00 
Lesotho 14 229,199.00 44,271.50 82,771.50 2,796.00 
Lesotho 49 600,007.00 121,390.50 224,865.00 7,490.00 
Morocco 1 13,242,616.50 4,386,423.50 8,186,000.00 272,409.00 
Morocco 4 9,819,052.50 3,059,153.50 5,703,002.00 190,014.00 
Morocco 14 5,899,932.00 1,973,055.50 3,680,791.50 122,030.50 
Morocco 49 11,587,125.00 3,784,741.00 7,071,203.00 235,508.50 
Madagascar 1 9,150,387.00 1,448,349.50 2,707,202.50 90,125.50 
Madagascar 4 6,782,766.00 1,015,311.50 1,897,325.50 63,300.50 
Madagascar 14 3,564,206.50 563,427.50 1,049,184.00 35,009.50 
Madagascar 49 7,966,524.50 1,244,623.50 2,321,257.00 77,440.00 
Mexico 1 46,024,528.50 13,801,739.50 25,788,652.50 858,167.00 
Mexico 4 34,417,215.50 9,459,831.00 17,652,017.50 588,526.00 
Mexico 14 21,097,465.50 6,179,136.00 11,554,982.50 384,123.00 
Mexico 49 40,449,264.50 11,850,318.50 22,128,971.50 737,192.50 
Mali 1 6,261,538.50 750,361.50 1,399,912.50 46,770.00 
Mali 4 4,479,076.50 497,581.50 928,693.00 30,937.00 
Mali 14 2,225,009.00 265,778.50 494,221.50 16,416.00 
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Mali 49 5,359,818.00 623,713.50 1,164,621.00 38,817.00 
Mozambique 1 10,132,075.50 1,434,436.00 2,675,563.50 89,192.00 
Mozambique 4 7,529,591.00 1,000,297.00 1,869,916.50 62,413.00 
Mozambique 14 3,939,631.00 555,317.50 1,035,085.50 34,251.00 
Mozambique 49 8,820,156.50 1,230,586.50 2,293,159.50 76,324.00 
Mauritania 1 1,535,219.00 254,585.50 475,932.50 15,814.50 
Mauritania 4 1,165,275.50 182,691.50 339,829.50 11,333.00 
Mauritania 14 707,749.50 121,283.50 227,135.00 7,523.50 
Mauritania 49 1,353,942.00 221,412.00 412,271.50 13,722.50 
Mauritius 1 486,885.50 209,370.00 390,331.50 13,047.50 
Mauritius 4 351,304.50 138,424.00 258,993.50 8,630.00 
Mauritius 14 214,209.50 88,073.00 165,625.00 5,463.00 
Mauritius 49 422,540.50 176,489.00 329,162.50 11,015.50 
Malawi 1 6,206,020.50 853,281.00 1,590,558.50 52,895.50 
Malawi 4 4,609,105.50 597,183.50 1,114,078.50 37,180.00 
Malawi 14 2,414,871.50 329,973.00 616,215.00 20,405.50 
Malawi 49 5,394,534.00 731,214.50 1,362,680.00 45,337.50 
Namibia 1 805,968.50 113,124.50 211,467.00 7,031.50 
Namibia 4 594,974.50 78,583.00 146,712.50 4,861.00 
Namibia 14 271,679.50 36,560.50 68,778.50 2,296.50 
Namibia 49 696,764.50 95,833.50 179,065.50 5,974.50 
Niger 1 7,479,840.50 911,995.00 1,704,345.00 56,835.50 
Niger 4 5,361,960.00 604,501.50 1,131,297.50 37,570.50 
Niger 14 2,656,777.50 323,438.50 603,880.50 20,051.50 
Niger 49 6,407,713.00 758,280.50 1,417,828.00 47,137.00 
Nigeria 1 67,998,172.00 10,931,386.50 20,404,287.00 679,437.50 
Nigeria 4 51,622,542.50 7,976,219.00 14,878,213.00 495,446.50 
Nigeria 14 28,071,652.50 4,656,256.00 8,692,204.50 289,283.50 
Nigeria 49 59,789,002.00 9,541,919.50 17,807,958.50 593,371.50 
Nicaragua 1 2,235,573.00 500,811.00 937,662.50 31,193.00 
Nicaragua 4 1,671,927.50 340,380.50 632,680.50 21,123.50 
Nicaragua 14 917,568.00 190,082.50 355,496.00 11,913.00 
Nicaragua 49 1,954,965.00 422,935.50 790,201.00 26,307.50 
Nepal 1 9,915,594.50 2,499,733.50 4,665,603.00 155,338.50 
Nepal 4 7,426,283.00 1,746,579.00 3,269,303.00 108,873.50 
Nepal 14 3,596,042.00 931,577.50 1,736,856.00 57,692.50 
Nepal 49 8,680,618.50 2,156,185.00 4,028,305.50 134,340.50 
Oman 1 1,535,261.00 176,798.50 329,421.00 10,993.00 
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Oman 4 1,072,384.00 107,046.00 199,923.00 6,631.00 
Oman 14 551,427.00 50,614.00 93,722.50 3,132.50 
Oman 49 1,289,638.50 138,700.50 258,894.00 8,678.00 
Pakistan 1 71,833,290.50 13,106,615.00 24,490,690.50 816,437.00 
Pakistan 4 53,017,172.50 8,893,216.00 16,571,105.50 551,824.00 
Pakistan 14 29,435,591.50 5,229,562.50 9,784,165.00 324,959.50 
Pakistan 49 62,541,662.00 10,974,825.00 20,499,024.50 682,425.00 
Panama 1 1,517,972.50 471,387.00 879,487.50 29,338.50 
Panama 4 1,105,635.50 311,636.50 581,917.50 19,376.00 
Panama 14 599,862.50 178,411.50 335,181.00 11,120.50 
Panama 49 1,313,913.50 396,995.50 740,170.50 24,635.00 
Peru 1 11,655,014.00 3,620,110.00 6,750,234.00 224,803.00 
Peru 4 8,460,494.50 2,403,019.00 4,479,917.00 148,873.00 
Peru 14 4,169,860.50 1,246,737.00 2,324,155.00 77,271.50 
Peru 49 10,081,293.50 3,039,427.50 5,677,001.50 188,946.00 
Paraguay 1 2,401,204.50 602,571.50 1,122,937.50 37,455.50 
Paraguay 4 1,771,743.00 398,632.00 744,466.50 24,878.00 
Paraguay 14 880,973.50 208,728.50 389,898.50 12,896.50 
Paraguay 49 2,085,255.00 508,236.50 946,491.00 31,507.00 
West Bank and Gaza 1 1,594,003.50 226,570.50 422,739.00 14,105.00 
West Bank and Gaza 4 1,189,222.50 151,665.50 281,435.00 9,406.50 
West Bank and Gaza 14 712,802.50 95,452.50 176,325.50 5,948.50 
West Bank and Gaza 49 1,387,924.50 190,382.00 355,232.00 11,799.00 
Qatar 1 899,032.50 113,926.50 212,464.50 7,071.00 
Qatar 4 641,023.00 70,589.50 132,073.50 4,377.50 
Qatar 14 266,723.50 26,536.00 49,248.00 1,647.50 
Qatar 49 766,587.00 89,823.50 168,594.50 5,584.50 
Rwanda 1 4,260,092.00 653,278.50 1,221,703.50 40,608.00 
Rwanda 4 3,212,134.50 457,874.00 855,829.50 28,478.00 
Rwanda 14 1,749,170.00 255,902.00 479,833.50 16,021.50 
Rwanda 49 3,746,403.00 557,316.50 1,041,050.00 34,717.00 
Saudi Arabia 1 11,941,083.50 2,049,485.00 3,823,720.50 127,556.50 
Saudi Arabia 4 8,911,360.50 1,384,909.50 2,587,572.50 86,282.50 
Saudi Arabia 14 5,395,467.50 824,158.50 1,538,146.50 51,054.00 
Saudi Arabia 49 10,445,557.00 1,719,131.00 3,203,677.50 106,843.00 
Sudan 1 14,419,983.00 2,514,130.50 4,680,808.50 155,985.00 
Sudan 4 10,877,482.50 1,772,405.50 3,314,864.00 110,203.50 
Sudan 14 5,777,423.00 1,008,371.50 1,878,300.50 62,797.00 
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Sudan 49 12,629,479.00 2,164,740.50 4,038,214.50 134,408.50 
Senegal 1 5,506,929.50 943,941.00 1,765,632.50 58,633.50 
Senegal 4 4,152,655.50 688,535.00 1,284,545.00 42,863.00 
Senegal 14 2,285,377.00 427,813.00 800,324.00 26,502.50 
Senegal 49 4,809,000.50 828,513.50 1,548,749.50 51,440.50 
Sierra Leone 1 2,630,770.00 424,739.50 793,709.50 26,428.50 
Sierra Leone 4 1,994,333.00 307,273.00 574,350.00 19,119.50 
Sierra Leone 14 1,158,003.00 191,212.00 360,302.00 12,060.50 
Sierra Leone 49 2,319,759.00 370,961.50 690,722.50 22,966.50 
El Salvador 1 2,258,281.50 726,963.50 1,354,593.00 45,160.50 
El Salvador 4 1,664,921.50 490,165.50 916,503.50 30,630.00 
El Salvador 14 908,668.00 289,893.50 538,904.50 17,905.50 
El Salvador 49 1,965,853.00 619,690.50 1,156,953.50 38,540.00 
Somalia 1 5,054,908.00 722,092.50 1,346,267.50 44,904.50 
Somalia 4 3,796,053.50 508,883.00 947,770.50 31,691.00 
Somalia 14 1,969,685.00 281,476.00 522,971.00 17,450.00 
Somalia 49 4,408,720.50 619,059.00 1,154,447.00 38,523.50 
South Sudan 1 3,696,526.00 575,956.50 1,078,140.00 35,884.00 
South Sudan 4 2,762,595.00 406,328.00 758,511.00 25,346.00 
South Sudan 14 1,282,595.00 203,062.00 381,821.00 12,566.00 
South Sudan 49 3,220,523.50 493,716.50 922,740.50 30,649.50 
Sao Tome and Principe 1 72,283.50 11,231.50 20,945.00 696.00 
Sao Tome and Principe 4 54,913.00 8,013.50 15,109.50 500.00 
Sao Tome and Principe 14 29,481.50 4,448.00 8,484.00 283.50 
Sao Tome and Principe 49 63,572.00 9,662.00 17,970.50 606.50 
Eswatini 1 363,364.00 62,143.50 115,928.00 3,869.00 
Eswatini 4 266,346.00 40,923.50 76,890.50 2,558.00 
Eswatini 14 119,567.50 18,886.00 35,996.50 1,187.00 
Eswatini 49 313,533.00 51,987.50 96,273.50 3,204.00 
Seychelles 1 35,263.00 12,022.50 22,569.50 746.00 
Seychelles 4 25,064.00 7,926.50 14,905.00 495.50 
Seychelles 14 14,434.00 4,800.50 8,982.50 294.50 
Seychelles 49 30,440.50 10,024.50 18,709.50 625.00 
Syrian Arab Republic 1 5,792,480.00 989,564.50 1,847,430.00 61,580.00 
Syrian Arab Republic 4 4,370,151.50 718,417.00 1,339,837.50 44,443.00 
Syrian Arab Republic 14 2,590,708.00 461,948.50 861,860.00 28,637.00 
Syrian Arab Republic 49 5,101,506.50 858,728.00 1,601,689.50 53,348.50 
Chad 1 5,065,942.50 601,091.00 1,124,428.00 37,284.50 
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 25, 2020. ; https://doi.org/10.1101/2020.08.23.20180299doi: medRxiv preprint 
Chad 4 3,620,549.50 399,236.00 745,414.50 24,835.00 
Chad 14 1,795,297.50 213,052.50 398,405.50 13,124.00 
Chad 49 4,330,613.50 500,212.50 933,773.00 31,055.00 
Togo 1 2,738,321.50 409,696.00 766,658.50 25,515.50 
Togo 4 2,084,481.50 294,394.50 549,644.00 18,293.50 
Togo 14 1,117,765.50 165,863.50 310,016.00 10,260.50 
Togo 49 2,416,837.50 353,371.50 660,994.00 21,999.00 
Tajikistan 1 2,980,380.50 506,624.00 946,025.50 31,461.00 
Tajikistan 4 2,132,996.50 334,988.50 624,270.50 20,882.50 
Tajikistan 14 1,073,616.50 173,478.00 325,632.50 10,814.50 
Tajikistan 49 2,558,536.50 423,792.00 791,527.50 26,444.00 
Tunisia 1 4,156,065.00 1,421,020.00 2,652,235.00 88,351.50 
Tunisia 4 2,993,242.50 934,481.50 1,744,116.00 58,013.50 
Tunisia 14 1,711,642.00 556,560.50 1,039,231.00 34,717.50 
Tunisia 49 3,578,598.00 1,197,555.50 2,241,228.00 74,470.50 
Turkey 1 31,029,721.00 11,408,352.00 21,265,807.50 708,020.00 
Turkey 4 23,141,897.50 7,967,971.50 14,847,503.50 495,399.50 
Turkey 14 14,342,055.00 5,342,495.00 9,982,584.00 331,482.50 
Turkey 49 27,262,980.00 9,879,607.50 18,427,321.50 614,391.00 
Tanzania 1 19,439,044.50 2,891,250.00 5,398,275.50 180,022.50 
Tanzania 4 14,683,606.50 2,076,715.50 3,872,581.00 129,155.00 
Tanzania 14 7,943,080.00 1,196,374.50 2,231,611.50 74,239.50 
Tanzania 49 17,106,351.50 2,514,752.00 4,689,457.00 156,667.50 
Uganda 1 14,035,584.50 2,241,331.50 4,179,978.50 139,292.00 
Uganda 4 10,795,699.00 1,767,713.00 3,302,956.50 109,887.00 
Uganda 14 9,634,472.00 1,547,767.00 2,892,963.50 96,319.50 
Uganda 49 12,625,196.50 2,044,288.00 3,816,799.50 126,941.00 
Uruguay 1 1,326,201.50 679,333.50 1,267,820.00 42,256.00 
Uruguay 4 938,231.00 445,262.00 828,683.00 27,689.50 
Uruguay 14 516,148.00 261,647.50 487,979.00 16,297.00 
Uruguay 49 1,141,786.50 570,625.00 1,062,322.00 35,429.00 
Venezuela, RB 1 10,135,488.00 3,272,693.50 6,112,276.00 203,631.50 
Venezuela, RB 4 7,385,224.00 2,226,216.00 4,152,468.50 138,283.50 
Venezuela, RB 14 4,478,616.50 1,444,018.50 2,687,084.50 89,718.00 
Venezuela, RB 49 8,782,756.00 2,799,109.50 5,232,723.50 173,968.50 
Yemen, Rep. 1 8,978,939.50 1,189,341.00 2,223,058.50 74,107.50 
Yemen, Rep. 4 6,443,445.50 752,402.00 1,407,658.50 46,808.50 
Yemen, Rep. 14 3,134,621.00 389,461.00 723,166.50 23,984.50 
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Yemen, Rep. 49 7,619,708.50 969,122.50 1,816,360.50 60,463.00 
South Africa 1 20,484,691.50 4,996,026.50 9,320,556.00 310,571.50 
South Africa 4 15,232,036.50 3,438,007.00 6,410,413.00 213,792.00 
South Africa 14 8,795,217.00 2,079,588.50 3,890,084.50 129,416.00 
South Africa 49 17,929,452.50 4,284,328.50 7,988,411.00 266,130.00 
Zambia 1 5,908,589.50 719,278.00 1,341,163.00 44,602.50 
Zambia 4 4,464,221.00 514,499.50 966,758.00 32,042.50 
Zambia 14 2,130,687.00 259,718.00 486,323.50 16,191.50 
Zambia 49 5,177,648.00 620,034.50 1,154,007.00 38,561.00 
Zimbabwe 1 4,572,303.50 991,498.50 1,852,341.50 61,683.50 
Zimbabwe 4 3,484,742.00 817,788.00 1,524,034.50 50,874.50 
Zimbabwe 14 3,275,359.00 779,772.50 1,450,085.50 48,299.00 
Zimbabwe 49 4,110,615.00 926,563.00 1,728,563.00 57,739.50 
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We summarise here the main parameters used in the estimates of health resources and costing. 
Further details and references are then provided in the following sections. 
In summary, there are four steps in our calculations: 
1. Calculation of unit costs per activity for three base countries: Ethiopia (low-income country 
or ‘LIC’), Pakistan (lower-middle income country or ‘LMIC’) and South Africa (upper-middle 
income country or ‘UMIC’) 
2. Extrapolation of unit costs in base countries to calculate unit costs across 84 LICs, LMICs and 
UMICs 
3. Calculation of total costs per country using country-specific unit costs, modelled data on the 
number of cases, hospitalisations and deaths, as well as other epidemiological and economic 
assumptions 
4. Calculation of country-specific per capita costs, as well as per capita costs as a proportion of 
gross domestic product (GDP) per capita and various measures of health expenditure per 
capita 
 
S2.2 Calculation of unit costs per activity for three base countries 
 
 
S2.2.1 General Approach 
 
A full economic costing was carried out over a one-year time horizon. Costs were constructed using a 
bottom-up ingredients-based technique. The costing was carried out from a health systems 
perspective and included both direct (e.g. medicines) and indirect costs (e.g. facility overheads). No 
above-service delivery costs were included. 
 
The eighty-four countries chosen met three inclusion criteria: 1) be classified as low-income, lower-
middle income or upper-middle income by the World Bank [17], 2) be included in the list of 92 
countries for which epidemiological modelling data was available from Pearson et al (2020) [16], and 
3) have recent available GDP per capita data in order to carry out cost extrapolation between 
countries [17].  
 
 
S2.2.2 Intervention costs 
 
We used official WHO guidance to identify areas related to critical preparedness, readiness and 
response actions for COVID-19 to define a set of interventions involved in a national response to the 
pandemic. This guidance identifies 6 priority areas of work and is further sub-divided into 13 
activities.   
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• Emergency response mechanisms at the national level  
• Risk communication and community engagement 
• Case finding, contact tracing and management  
• Surveillance 
• Public health measures 
• Case management  
 
 
For the first five areas of work we considered only WHO guidance to define the resource use. For 
case management costs we assumed less resource-intensive activities that we felt were more 
plausible in low- and middle-income settings (‘real-world’). Assumptions on ‘real world’ resource use 
were based on the clinical expertise of members of the research team and are detailed below.  
 
Following this guidance, we generated a list of unit costs to be brought together with the COVID 
epidemiological model to estimate resource needs, as detailed in Table S2.2. 
 
Table S2.2.2.1 Intervention description and unit costs 
 
Activity Activity unit costs 
1.a. Emergency Response Mechanisms: National level Per country per day 
1.b. Emergency Response Mechanisms: Training of health staff One-off per site 
2. Risk communication & community engagement Per country per day 
3.a. Case finding, contact tracing and management: Contact tracing Per person contacted 
3.b. Case finding, contact tracing and management: Quarantine of 
contacts 
Per person quarantined 
4.a. Surveillance: Case notification Per positive case 
4.b. Surveillance: Reporting (national level) Per country per week 
5. Public health measures: Hygiene education Per education campaign per month 
6. Screening and diagnosis Per person screened and tested 
7.a. Case Management: Home-based care Per person requiring home-based care 
7.b. Case Management: Hospital-based (severe case) Per day of hospitalisation (severe case) 
7.c. Case Management: Hospital-based (critical case) Per day of hospitalisation (critical case) 
7.d. Case Management: Death Per COVID-related death 
 
S.2.2.3. Defining Inputs, Costs per Input and Quantities of Inputs 
 
For each of the abovementioned activities we used an ingredients based costing to identify a series 
of inputs (e.g. junior-level government worker day). For each input we estimated a number of units 
(e.g. three days of work) and a country-specific price. The costs of each input were identified using a 
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range of sources, according to availability of recent primary cost data and appropriateness of cost 
estimates to the COVID pattern of care. See the table below.  
 
Table S2.2.3.1 Quantities and Unit Costs per Input per Activity per Country 
 
Component Number of 
Units per 
Input 
Unit Cost per Inputs 
Ethiopia Pakistan South Africa 
1.a. Emergency Response Mechanisms: National level 
Working day (junior level govt) 10  $                              12.27   $                              13.07   $                            194.66  
Working day (senior level govt) 10  $                              17.29   $                              23.94   $                            256.72  
Meeting/ training costs per person per day 20  $                              13.18   $                              20.44   $                            159.17  
Total:  $                           559.26   $                           778.90   $                        7,697.16  
1.b. Emergency Response Mechanisms: Training of health staff 
Working day (health care workers) 250  $                                4.93   $                              10.43   $                              97.58  
Working day (junior level govt) 10  $                              12.27   $                              13.07   $                            194.66  
Working day (senior level govt) 1  $                              17.29   $                              23.94   $                            256.72  
Meeting/ training costs per person per day 261  $                              13.18   $                              20.44   $                            159.17  
Total:  $                        4,813.58   $                        8,096.53   $                      68,141.36  
2. Risk communication & community engagement 
Working day (junior level govt) 3  $                              12.27   $                              13.07   $                            194.66  
Working day (senior level govt) 2  $                              17.29   $                              23.94   $                            256.72  
Media costs per day 1  $                                2.74   $                                4.58   $                              36.00  
Total:  $                             74.14   $                             91.67   $                        1,133.44  
3.a. Case finding, contact tracing and management: Contact tracing 
Working day (junior level govt) 0.1  $                              12.27   $                              13.07   $                            194.66  
Contact tracing household visit 0.33  $                                2.08   $                                3.02   $                              13.68  
Contact tracing phone call 0.67  $                                2.34   $                                0.34   $                                3.31  
Total:  $                               3.48   $                               2.54   $                             26.23  
3.b. Case finding, contact tracing and management: Quarantine of contacts 
Working day (health care workers) 0.1  $                                4.93   $                              10.43   $                              97.58  
Working day (junior level govt) 0.1  $                              12.27   $                              13.07   $                            194.66  
Total:  $                               1.72   $                               2.35   $                             29.22  
4.a. Surveillance: Case notification 
Working day (health care workers) 0.1  $                                4.93   $                              10.43   $                              97.58  
Working day (junior level govt) 0.1  $                              12.27   $                              13.07   $                            194.66  
Total:  $                               1.72   $                               2.35   $                             29.22  
4.b. Surveillance: Reporting (national level) 
Working day (health care workers) 0.5  $                                4.93   $                              10.43   $                              97.58  
Working day (junior level govt) 0.1  $                              12.27   $                              13.07   $                            194.66  
Total:  $                               3.69   $                               6.52   $                             68.26  
5. Public health measures: Hygiene education 
Working day (junior level govt) 2  $                              12.27   $                              10.43   $                              97.58  
Working day (senior level govt) 1  $                              17.29   $                              13.07   $                            194.66  
Media costs per day 1  $                                2.74   $                                4.58   $                              36.00  
Total:  $                             44.58   $                             38.51   $                           425.83  
6. Screening and diagnosis 
Ambulance trip 0.0001  $                                4.80   $                                9.51   $                              60.41  
Isolation pod/ diagnostic visit 2  $                                0.49   $                                0.49   $                                7.97  
Outpatient visit oral history 1  $                                3.57   $                                0.47   $                                8.02  
Outpatient visit physical exam 1  $                                3.57   $                                0.47   $                                8.02  
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Outpatient visit specimen collection 1  $                                4.88   $                                1.09   $                              17.15  
COVID19 test (PCR) 1  $                              23.98   $                              23.98   $                              23.98  
Total:  $                             36.97   $                             26.98   $                             73.12  
7.a. Case Management: Home-based care 
Home-based care bed-day 5  $                                0.94   $                                0.61   $                              11.65  
Community-based care via GP 2  $                                9.11   $                                4.71   $                              44.16  
Total:  $                             22.90   $                             12.45   $                           146.57  
7.b. Case Management: Hospital-based (severe case) 
Inpatient ward bed-day (severe) 1  $                              29.90   $                              31.54   $                              96.66  
Diagnostics         
Pulse oximetry 0.125  $                                0.00   $                                0.00   $                                0.00  
Chest X-ray 0.125  $                              27.35   $                                2.79   $                              21.86  
Full blood count 0.125  $                                2.37   $                                2.29   $                              24.28  
Blood urea and electrolyte test 0.125  $                                4.20   $                                2.53   $                                2.87  
C-reactive protein test 0.125  $                                2.34   $                                0.32   $                                5.15  
HIV test 0.125  $                                4.38   $                                3.87   $                              17.13  
COVID19 test (PCR) 0  $                              23.98   $                              23.98   $                              23.98  
Malaria test 0.125  $                                0.19   $                                0.19   $                                0.19  
Haemoglobin test 0.125  $                                2.29   $                                2.29   $                                2.29  
Total:  $                               35.29   $                               33.32   $                               105.88  
7.c. Case Management: Hospital-based (critical case) 
Inpatient ward bed-day (critical) 0.33 30.65 32.29 97.41 
ITU bed-day 0.67  $                            104.48   $                            101.99   $                            662.71  
Additional resourcing per COVID-related complication         
Acute respiratory distress syndrome (ARDS)  0.47  $                              22.46   $                              22.46   $                              22.46  
Acute kidney injury days 0.04  $                              10.60   $                              10.60   $                              10.60  
Acute cardiac injury days 0.06  $                              46.25   $                              46.25   $                              46.25  
Liver dysfunction days 0.06  $                              89.32   $                              89.32   $                              89.32  
Pneumothorax days 0.01  $                                6.66   $                                6.77   $                                7.02  
Hospital-acquired pneumonia days 0.05  $                              18.85   $                              18.85   $                              18.85  
Bacteraemia days 0.01  $                              32.55   $                              32.55   $                              32.55  
Urinary tract infection days 0.01  $                                9.03   $                                9.03   $                                9.03  
Septic shock days 0.05  $                                0.64   $                                0.67   $                                0.75  
Diagnostics         
Pulse oximetry 10  $                                0.00   $                                0.00   $                                0.00  
Chest X-ray 10  $                              27.35   $                                2.79   $                              21.86  
Full blood count 10  $                                2.37   $                                2.29   $                              24.28  
Blood urea and electrolyte test 10  $                                4.20   $                                2.53   $                                2.87  
C-reactive protein test 10  $                                2.34   $                                0.32   $                                5.15  
Venous blood gas test 10  $                                4.23   $                                4.23   $                                4.23  
HIV test 0.1  $                                4.38   $                                3.87   $                              17.13  
COVID19 test (PCR) 0  $                              23.98   $                              23.98   $                              23.98  
Malaria test 0.1  $                                0.19   $                                0.19   $                                0.19  
Haemoglobin test 0.1  $                                2.29   $                                2.29   $                                2.29  
Total:  $                            505.56   $                            221.18   $                         1,081.94  
7.d. Case Management: Death 
Body Bag 1  $                              64.52   $                              64.52   $                              64.52  
Total:  $                              64.52   $                              64.52   $                              64.52  
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S.2.2.4 Quantities  
 
Planning and Management Activities (Activities 1-5) 
Quantities of working days required for planning and management activities were estimated from 
expert consultation as part of the Diseases Control Priorities project. For other activities, quantities 
were estimated based on requirements for similar activities for tuberculosis (TB) such as contact 
tracing from the VALUE TB study and previous studies in South Africa (more below). 
 
Diagnosis and Clinical Management (Activities 6-7) 
 
The number of days per patient in general ward and in ICU was set at 8 and 10 respectively, and was 
set to match the assumptions in the epidemiological model [16, 19, 20]. Following expert clinician 
advise we assumed that one-third of critical patient bed days would be treated the general ward and 
two-thirds in the ICU.  
 
The likelihood of additional COVID-related complications (per day) were estimated using evidence 
on the clinical course of COVID from patients in Wuhan, China17, as were assumptions on the 
duration of symptoms18 [21]. The number of diagnostic tests per hospitalisation was carried out in 
consultation with expert clinicians in essential critical care.  
S.2.2.5 Input unit costs  
 
S2.2.5.1 Estimation of non-bed-day costs (Pakistan) 
 
An ingredients-based approach was used to calculate most of the service costs and prices for 
Pakistan. The data used was collected as part of the Disease Control Priorities 3-Universal Health 
Coverage (DCP3-UHC) project. For other countries primary data from the TB studies was used (see 
below). 
For Pakistan, staff-related costs were constructed using federal-level pay scales. For most outputs, 
the number of minutes of staff required per activity were estimated via expert opinion obtained 
from clinicians working in the Health Planning, System Strengthening & Information Analysis Unit 
(HPSIU) in the Ministry of National Health Services Regulations and Coordination of Pakistan. For 
outputs where this was unavailable, health economists agreed a plausible assumed value. 
Drug regimens were costed using resource use data obtained through expert opinion (HPSIU) and a 
number of price sources. An assessment of strengths and weaknesses of different price sources was 
conducted and hierarchy of sources was established. The primary source of price data was the Sindh 
Health Department Procurement Price list. If a price was unavailable, the Federal Wholesale Price 
List for Generic Medicines was used as a second option. As a last resort, private sector market prices 
were used. 
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Cost on supplies and equipment were similarly constructed. Resource use was determined through 
expert opinion (HPSIU) and price source hierarchy established. The primary source was the Medical 
Emergency Resilience Fund 2019-2020, and a secondary source was private sector market prices. 
For all countries, for additional diagnostic and radiology costs (beyond those available from the TB 
data) were estimated using available literature and market prices. We assessed strengths and 
weaknesses of different price sources. For example, we used the ‘Costing and Pricing of Services in 
Private Hospitals of Lahore: Summary Report’ as our primary source as it contained a methodological 
appendix that suggested that an ingredients-based approach consistent with ours was followed. If 
some prices were unavailable we used user fees from the Pakistan Institute of Medical Sciences, 
procurement prices from the Medical Emergency Resilience Fund procurement prices and user fees 
from the Aga Khan University Hospital. Space costs were estimated using data from budget 
documents from the Federal government (Islamabad Capital Territory Health Infrastructure PC-1). 
Oxygen therapy costs per bed-day were calculated by estimating the number of cylinders consumed 
in 24 hours at different flow rates, assumed to be 10L per minute in the general ward and 30L per 
minute in the ICU. Cylinder duration (hours) was estimated by dividing pressure by the number of 
litres per minute, assuming a standard cylinder size of 4.6kg, filled at 1,900 psi pressure [22]. Cost 
per cylinder was obtained from the South African online catalogue of a manufacturer that is active in 
both South Africa and Pakistan [23].  
S2.2.5.2 Estimation of non-bed-day costs (Ethiopia and South Africa) 
 
For Ethiopia the main source of cost data was the VALUE TB study. Cost data collected from a health 
provider perspective to estimate the economic costs of TB-related health services.  Full costs of 
health services were estimated, reflecting their implementation in the ‘real world’ rather than using 
a ‘per protocol’ costing approach.  Cost data collection was retrospective, over a one-year period to 
minimize the risk of bias due to seasonality. Resource use was measured in the VALUE TB study using 
both top-down and bottom-up methods wherever possible, to allow for comparison. The costs 
included in the current cost model reflected an average of top-down and bottom-up costs by site.   
For South Africa, we used primary data from the XTEND trial (nurses and lay health workers)19. This 
was updated using more recent data on contact tracing and update prices collected on an on-going 
trial of TB preventative therapy (WHIP3TB) (ClinicalTrials.gov, 2020). 
Some of the COVID-19 interventions were outside the scope of the VALUE TB, XTEND, and WHIP3TB 
studies. Values for which a primary unit cost was partially or entirely unavailable from Value TB are 
listed in the Table below. For these interventions, resource use from Pakistan (DCP) was then used 
with local prices (see list below). 
 
Table S.2.2.5.3.1Inputs for which unit costs were estimated for South Africa and Ethiopia using 
resource use from DCP 
 
Planning & coordination activities 
Working day (mid-level facility)
 
 
Working day (junior level govt)
 
 
Working day (senior level govt)
 
 
Meeting/ training costs per day 
Media costs per day 
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Health hotline (day) 
Infection control 
Ambulance trip 
Isolation pod/ diagnostic visit 
Deep clean 
Home-based care 
Home-based care bed-day 
community-based care via GP 
Inpatient treatment 
Inpatient ward bed-day including PPE (normative scenario)  
ICU bed-day, including PPE (normative scenario)  
Severe case ward bed-day, including PPE  
Critical case ward bed-day, including PPE  
ITU bed-day (‘real-world scenario’) 
Body disposal 
Additional resourcing per COVID related complication 
Acute respiratory distress syndrome (ARDS)  
Acute kidney injury  
Acute cardiac injury  




Urinary tract infection  
Septic shock  
Investigations (lab tests) 
Pulse oximetry 
Venous blood gas  
Mid-stream urine test  





Where costs were applied from Pakistan health care inputs were classified as either tradeable, as in 
the case of medical equipment and supplies for diagnostic tests and procedures, and non-tradeable, 
including non-medical supplies, capital and overhead costs. For tradable inputs, where country-
specific price estimates were not available from primary data or from the published literature, the 
estimate from Pakistan was applied to other countries. For non-tradable inputs, the estimate from 
Pakistan was adjusted by an amount reflecting the difference in the two countries’ GDP (PPP). The 
rationale behind this approach is that, while exchange rate may be influenced by government policy, 
PPP seeks to equalise the purchasing power of different currencies and, as such, may better reflect 
differentials in salaries and other non-tradable prices across countries. 
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Table S2.2.5.4 Relative GDP adjustment factors 
 
   Relative GDP (PPP) 








Kenya India Ethiopia 
Pakistan 155.00  5,567.06 1.00  0.41       0.87        0.72        2.75  
South Africa   32.26  2,022.14 2.46  1.00        3.73        1.76        6.77  
Kenya   76.92  7,762.88 0.62  0.25        1.00        0.45        1.71  
India 104.17  3,467.56 1.39  0.57        1.18        1.00        3.84  
Ethiopia   16.95  13,686.88 0.36  0.15        0.45        0.26        1.00  
 
 
S2.2.5.5 Estimation of bed-day costs (all countries) 
 
We took an ingredients approach to estimating the costs of general ward and ICU ward bed days, as 
these were major cost drivers in our cost model. We estimated the plausible number of nursing 
hours per bed day in an LMIC setting through consultation with members of the research team who 
have expertise in critical care in LMICs. In ICU the assumption of nurse to patient ratio would be 1:1; 
in the general ward the ratio would be 1:6 during the day time and 1:20 in the night.    
To understand the full range of inputs required we obtained the underlying costing data set 
provided by the authors of a recent primary costing of critical carer20. The paper reports the results 
of a detailed activity-based costing in a hospital in Karachi, disaggregated by phase of care. We used 
the cost data for the ward stay phase, removing any supplies or equipment specific to the surgery, to 
estimate the average generic costs of a bed-day.  
All bed-day costs were compared to and validated against available country-specific estimates from 
the published literature and from ongoing research and WHO CHOICE (see Table S2.4). Rapid 





April 2020 to identify records reporting on the costs of ICU care in each of the study countries (see 
table below).  
Table S2.2.5.5.1 Comparison of bed-day costs by setting 
 
  Unit cost (2019 US$)   
  Extrapolated From literature Source 
Kenya 362.49 349.25 (Lalani et al., 2018) 
India 512.44 585.80 (Mathai et al., 2015) 
South Africa 1240.96 1644.27 (Mahomed and Mahomed, 2019) 
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We estimated the additional costs of ICU beds compared to standard hospital beds using an 
ingredients-based approach to cost the equipment and supplies not present in standard hospital 
wards. We used the procurement price of equipment and assumed depreciation over ten 
(ventilators and suction pumps) or five years (all other equipment). Supply costs included central and 
arterial lines, ventilator tubing, and sedatives. 
 
 
S2.2.5.6 COVID specific costs 
 
Finally, we calculated the costs of personal protective equipment (PPE) per health worker per day 
(see Table below) and allocated a cost per PPE per minute to clinical staff. We also calculated costs 
of hygiene per bed day. We estimated the costs of PPE and hygiene supplies using a list of necessary 
supplies from a COVID-related budget from the Ministry of Health of Pakistan, which included local 
prices sourced by the Aga Kahn University. This was complemented for other countries using the 
WHO’s Essential Supplies Forecasting Tool (ESFT) [7].  We divided supplies into single-use and 
disposable. We determined plausible quantities and useful life for supplies following clinical 
guidelines and expert opinion.  
 
Table S2.2.5.6.1 PPE costs per general ward bed day and per ICU bed day  
 






staff per day 
US$ 
Assumptions 
PPE for General 
Ward 
     
Single Use           
Surgical Gowns 0.20 1 1 0.20   
Nitrile Gloves 0.05 1 10 0.45   
Latex Gloves 0.04 1 10 0.39   
Disposable Head 0.03 1 4 0.10   
Shoe Covers  0.02 1 4 0.06   
Surgical Masks 0.08 1 10 0.77   
Reusable           
Goggles 11.61 90 1.5 0.19 Assuming half a day for washing 
Gum Boots  19.35 90 1.5 0.32 Assuming half a day for washing 
TOTAL       2.50   
PPE for ICU            
Single Use           
N-95 Masks 0.84 1 4 3.35   
Disposable apron 0.20 1 1 0.20   
Nitrile Gloves 0.05 1 10 0.45   
Latex Gloves 0.04 1 10 0.39   
Disposable Head 0.03 1 4 0.10   
Shoe Covers  0.02 1 4 0.06   
Surgical Masks 0.08 1 10 0.77   
Reusable           
Face Shields  27.81 5 1.5 8.34 Assuming half a day for washing 
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Goggles 11.61 90 1.5 0.19 Assuming half a day for washing 
Gum Boots  19.35 90 1.5 0.32 Assuming half a day for washing 
TOTAL       14.19   
 
Table S2.2.5.6.2 Hygiene costs per General Ward and ICU bed day  
 




Total per ICU bed 
per day USD 
Assumptions 
Single Use           
Hand Sanitizers  47.97 1 0.05 2.40  100ml use per day, price assumed to refer 
to bottle of 2000ml  
Biohazard Bags 0.23 1 1 0.23   
Disposable bed sheets 1.94 1 1 1.94   
Disposable Tissue 
Boxes 
0.65 1 1 0.65  1 box per day, price assumed to refer to 1 
box  




3.23 1 0.25 0.81  250ml used per day, price refers to bottle 
of 1000ml  
Liquid Soaps (250ml 
Dettol bottles) 
1.74 1 0.2 0.35  50ml used per day, price refers to bottle 
of 250ml  
Ethanol (1L bottles) 16.13 1 0.1 1.61  100ml used per day, price refers to bottle 
of 1000ml  
Liquid Bleach 2.58 1 0.25 0.65  250ml used per day, price assumed to 
refer to bottle of 1000ml  
Reusable           
Waste Bins  15.03 90 1 0.17   
Mackintosh bed 
sheets  
9.68 90 1 0.11   
Mops  2.58 90 1 0.03   
Dusters 0.32 90 1 0.00   
TOTAL       9.28   
 
 
Oxygen supplementation therapy is the main form of treatment for COVID 19. There are different 
methods of oxygen delivery which utilise different types of supplies, equipment and require 
different average levels of oxygen flow. We calculated costs for 6 types of oxygen delivery 
techniques and assumed a distribution across severe and critical patients according to members of 
our research team with clinical expertise in critical care in LMICs. See Table below.  
 
Table S2.2.5.6.3  
 
  
Normative recommendations Real-world' scenario 
















Acute respiratory distress syndrome (5% of 
COVID cases) 
  General ward ICU General ward General ward only ICU 
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Supplemental oxygen management type           
% ventilator 0% 100% 0% 0% 50% 
% CPAP 0% 0% 0% 0% 25% 
% high-flow nasal cannula 0% 0% 0% 0% 25% 
% non-rebreather mask 25% 0% 25% 100% 0% 
% nasal cannula 50% 0% 50% 0% 0% 
% high-concentration mask 25% 0% 25% 0% 0% 
% Patients in pathway 100% 100% 100% 33% 67% 
 
S2.3 Extrapolation of unit costs in base countries to calculate unit costs across 84 LICs, LMICs and 
UMICs 
 
We used the unit costs obtained in our three base countries to extrapolate unit costs to other LICs, 
LMICs and UMICs. We grouped countries according to income group. Costs for LICs were 
extrapolated using unit costs from Ethiopia, costs for LMICs were extrapolated from the unit costs 
from Pakistan, and those for UMICs from the unit costs from South Africa.  
In order to carry out the extrapolation, each cost ingredient for each of the unit costs was classified 
as a tradeable good, non-tradeable good, or staff cost.  
Tradeable goods are generally defined as those that can easily be traded in the international market 
and include goods such as medical or other supplies and medications. The unit costs for our three 
base countries were initially converted from each local currency into 2019 US$ using market 
exchange rates. To convert the tradeable good from the base country (e.g. Ethiopia) to a ‘second’ 
country (e.g. Afghanistan) we apportioned the percentage of the unit cost that was composed of 
tradeable goods in 2019 US$ from the base country to the second country.    
Non-tradeable goods include buildings, heavy machinery, and other equipment. To convert these 
costs from a base country to a second country we used purchasing power parity (PPP) conversion 
rates. We multiplied the proportion of the unit cost that was defined as non-tradeable (in 2019 US$) 
by the ratio of the 2019 GDP per capita (adjusted for PPP) of the second county, divided by the 2019 
GDP per capita (adjusted for PPP) of the base country. Data on GDP per capita (adjusted for PPP) can 
be found in the World Bank database [17].  
To convert staff costs from a base country to a second country we used conversion rates from Serje 
et al (2018) [18]. Serje et al (2018) use regression analysis on a dataset containing wages from health 
workers of different skill levels for 193 countries in order to predict wages by country income level 
relative to GDP per capita. We used the multiples per GDP per capita presented in the paper in order 
to convert the staff wages from the base country to the second country. See the table from Serje et 
al (2018) below.   
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Table S2.3.1 Health worker earnings as a multiple of GDP per capita (Serje et al 2018) 
 
World bank income categories Health worker cadre  Average earnings index 
(multiple of GDP per capita) 
High-income countries Physicians  1.9 
  Nurses and midwives  1.5 
  Other health workers  0.9 
Upper-middle income countries Physicians  2.7 
  Nurses and midwives  2.2 
  Other health workers  1.3 
Lower-middle income countries Physicians  5.1 
  Nurses and midwives  4.2 
  Other health workers  2.4 
Lower-income countries Physicians  7.8 
  Nurses and midwives  6.4 
  Other health workers  3.7 
Global Physicians  4.4 
  Nurses and midwives  3.6 
  Other health workers  2.1 
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S2.4 Calculation of total costs per country using country-specific unit costs, modelled data on the 
number of cases, hospitalisations and deaths, as well as other epidemiological and economic 
assumptions 
 
The unit cost in each of the 84 countries was used to calculate the total costs per activity per 
country. The table below explains the quantities that those unit costs were multiplied by in order to 
calculate the total costs per country.  
Table S2.4.1  
Activity Unit Type Quantities per country Value Source 
1.a. Emergency Response 
Mechanisms: National level 
Per country 
per day 
Number of working days per year 260 Assumption 
1.b. Emergency Response 




Total number of clinical sites * Variable per 
Country 
Calculated by assuming 
one site for every 200 
hospital beds available in 
the country [24] 




Number of calendar days per year 365 N/A 
3.a. Case finding, contact tracing 




Total number of COVID19 cases * Variable by 
country 
See Table S1.3.1 
    % cases that are symptomatic *  69% [25] 
    % of symptomatic cases tested *  10% Assumption 
    Average number of contacts per 
COVID19-positive case 
7 [26] 
3.b. Case finding, contact tracing 




Total number of COVID19 cases * Variable by 
country  
See Table S1.3.1 
    % cases that are symptomatic *  69% [25] 
    % of symptomatic cases tested *  10% Assumption 
    Average number of contacts per 
COVID19-positive case 
7 [26] 




Total number of COVID19 cases * Variable per 
Country 
See Table S1.3.1 
    % cases that are symptomatic *  69% [25] 
    % of symptomatic cases tested *  10% Assumption 




Total number of clinical sites * Variable per 
Country 
Calculated by assuming 
one site for every 200 
hospital beds available in 
the country [24] 
    Weeks per year 52 N/A 
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Months per year  12 N/A 
6. Screening and diagnosis Per person 
screened and 
tested 
(Total number of COVID19 cases *  Variable per 
Country 
See Table S1.3.1 
    % of cases requiring 
hospitalisation * 
18.50% [16, 19] 
    Number of people tested per 
positive case) + 
11.31 See Table 2.4.2 
    (Total number of COVID19 cases *  Variable per 
Country 
See Table S1.3.1 
    % cases that are symptomatic *  69% [25] 
    % of symptomatic cases tested *  10% Assumption 
    Number of people tested per 
positive case) 
11.31 See Table 2.4.2 






Proportion of borderline mild-to-
severe cases 
10% Assumption 
7.b. Case Management: 
Hospital-based (severe case) 
Per day of 
hospitalisation 
(severe case) 
Average number of days of 
hospitalisation for severe cases 
8 [16, 20] 
7.c. Case Management: 
Hospital-based (critical case) 
Per day of 
hospitalisation 
(critical case) 
Average number of days of 
hospitalisation for critical cases 
10 [16, 19] 
7.d. Case Management: Death Per COVID-
related death 




See Table S1.3.1 
 
Table 2.4.2. Test positivity rate by country and average 
Country % of positive tests Source 
South Africa 0.169 [27] 
Kenya  0.103 [26] 
Ethiopia 0.0739 [28] 
India 0.0612 [29] 
Pakistan 0.0351 [30] 
Average 0.08844  
 
 
S2.5 Calculation of country-specific per capita costs, as well as per capita costs as a proportion of 
gross domestic product (GDP) per capita and various measures of health expenditure per capita. 
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Total costs per country were used to calculate the COVID-19-related costs per capita per country per 
scenario by dividing the total costs by the population of the country [17]. The cost per capita was 
then calculated as a proportion of GDP per capita [17] and three measures of health expenditure per 
capita [31]: 1) total health expenditure including out-of-pocket payments, 2) total health 
expenditure excluding out-of-pocket payments, and 3) government health spending per capita. Data 
on GDP per capita and health expenditure per capita per country can be found in the table below. 
 

























per Capita (US$) 
Afghanistan LIC 37,172,386  $               520.90   $                  57.25   $               101.56   $                    2.94  
Albania UMIC 2,866,376  $            5,268.85   $               271.54   $               428.99   $               112.30  
Algeria UMIC 42,228,429  $            4,114.72   $               260.41   $               340.84   $               176.27  
American Samoa UMIC 55,465  $          11,466.69   $                        -     $                        -     $                        -    
Andorra HIC 77,006  $          42,029.76   $            3,834.73   $            5,433.69   $            1,884.00  
Angola LMIC 30,809,762  $            3,432.39   $                  95.22   $               128.75   $                  42.03  
Antigua and Barbuda HIC 96,286  $          16,726.98   $               623.11   $               823.69   $               377.32  
Argentina UMIC 44,494,502  $          11,683.95   $               955.20   $            1,106.11   $               710.94  
Armenia UMIC 2,951,776  $            4,212.07   $               358.84   $               648.24   $                  59.04  
Aruba HIC 105,845  $          25,630.27   $                        -     $                        -     $                        -    
Australia HIC 24,992,369  $          57,373.69   $            5,002.36   $            5,949.99   $            3,416.98  
Austria HIC 8,847,037  $          51,461.95   $            4,688.28   $            5,575.29   $            3,399.49  
Azerbaijan UMIC 9,942,334  $            4,721.18   $               268.16   $               479.78   $                  53.53  
Bahamas, The HIC 385,640  $          32,217.87   $            1,835.23   $            2,343.88   $               915.06  
Bahrain HIC 1,569,439  $          24,050.76   $            1,099.36   $            1,407.05   $               674.61  
Bangladesh LMIC 
161,356,03
9  $            1,698.26   $                  34.22   $                  58.82   $                    6.14  
Barbados HIC 286,641  $          17,949.28   $            1,163.84   $            1,689.63   $               534.05  
Belarus UMIC 9,485,386  $            6,289.94   $               317.99   $               431.83   $               195.40  
Belgium HIC 11,422,068  $          47,518.64   $            4,149.39   $            4,807.43   $            3,489.87  
Belize UMIC 383,071  $            4,884.74   $               303.60   $               373.04   $               201.37  
Benin LIC 11,485,048  $               901.54   $                  30.40   $                  43.62   $                    6.24  
Bermuda HIC 63,968  $          85,748.07   $                        -     $                        -     $                        -    
Bhutan LMIC 754,394  $            3,243.23   $                  91.34   $               109.72   $                  67.55  
Bolivia LMIC 11,353,142  $            3,548.59   $               213.02   $               272.71   $               139.95  
Bosnia and Herzegovina UMIC 3,323,929  $            6,065.67   $               443.78   $               571.07   $               314.14  
Botswana UMIC 2,254,126  $            8,258.64   $               379.92   $               399.86   $               212.50  
Brazil UMIC 
209,469,33
 $            8,920.76   $            1,015.93   $            1,458.48   $               337.53  
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3 
British Virgin Islands HIC 29,802  $                        -     $                        -     $                        -     $                        -    
Brunei Darussalam HIC 428,962  $          31,628.33   $               630.63   $               662.61   $               598.65  
Bulgaria UMIC 7,024,216  $            9,272.63   $               612.48   $               906.19   $               309.69  
Burkina Faso LIC 19,751,535  $               715.12   $                  40.94   $                  53.79   $                  16.42  
Burundi LIC 11,175,378  $               271.75   $                  18.46   $                  24.10   $                    5.38  
Cabo Verde LMIC 543,767  $            3,635.41   $               159.07   $               200.46   $                  90.33  
Cambodia LMIC 16,249,798  $            1,510.32   $                  77.67   $               123.16   $                  16.94  
Cameroon LMIC 25,216,237  $            1,533.74   $                  64.47   $               109.27   $                    8.60  
Canada HIC 37,058,856  $          46,232.99   $            4,458.21   $            5,109.89   $            3,274.29  
Cayman Islands HIC 64,174  $          81,124.51   $                        -     $                        -     $                        -    
Central African Republic LIC 4,666,377  $               475.72   $                  16.36   $                  23.41   $                    2.43  
Chad LIC 15,477,751  $               728.34   $                  31.69   $                  51.06   $                    5.98  
Channel Islands HIC 170,499  $          74,462.65   $                        -     $                        -     $                        -    
Chile HIC 18,729,160  $          15,923.36   $            1,190.55   $            1,604.50   $               696.10  
China UMIC 
1,392,730,0
00  $            9,770.85   $               398.33   $               541.36   $               231.09  
Colombia UMIC 49,648,685  $            6,667.79   $               340.37   $               408.97   $               215.85  
Comoros LMIC 832,322  $            1,415.26   $                  59.00   $               102.15   $                    8.59  
Congo, Dem. Rep. LIC 84,068,091  $               561.78   $                  20.52   $                  28.20   $                    2.51  
Congo, Rep. LMIC 5,244,363  $            2,147.77   $                  70.38   $               105.37   $                  29.75  
Costa Rica UMIC 4,999,441  $          12,027.37   $               888.85   $            1,085.68   $               664.48  
Cote d'Ivoire LMIC 25,069,229  $            1,715.53   $                  67.57   $                  94.70   $                  17.41  
Croatia HIC 4,089,400  $          14,909.69   $               884.49   $            1,020.36   $               692.08  
Cuba UMIC 11,338,138  $            8,821.82   $               970.65   $            1,070.70   $               869.70  
Curacao HIC 159,849  $          19,567.89   $                        -     $                        -     $                        -    
Cyprus HIC 1,189,265  $          28,159.30   $            1,634.43   $            2,368.67   $               689.75  
Czech Republic HIC 10,625,695  $          23,078.57   $            1,321.62   $            1,520.18   $            1,082.12  
Denmark HIC 5,797,446  $          61,350.35   $            5,565.59   $            6,328.77   $            4,681.91  
Djibouti LMIC 958,920  $            3,082.54   $                  70.19   $                  88.28   $                  32.13  
Dominica UMIC 71,625  $            7,691.35   $               419.37   $               541.60   $               269.47  
Dominican Republic UMIC 10,627,165  $            8,050.63   $               414.18   $               598.97   $               189.38  
Ecuador UMIC 17,084,357  $            6,344.87   $               504.78   $               709.13   $               258.41  
Egypt, Arab Rep. LMIC 98,423,595  $            2,549.13   $               130.99   $               212.18   $                  38.38  
El Salvador LMIC 6,420,744  $            4,058.25   $               293.87   $               373.69   $               189.45  
Equatorial Guinea UMIC 1,308,974  $          10,261.76   $               281.37   $               486.31   $                  66.16  
Eritrea LIC ..  $               811.38   $                  29.89   $                  47.54   $                    8.73  
Estonia HIC 1,320,884  $          23,266.35   $            1,185.33   $            1,454.24   $               893.89  
Eswatini LMIC 1,136,191  $            4,145.97   $               220.59   $               242.42   $               152.88  
Ethiopia LIC 
109,224,55
9  $               772.31   $                  27.52   $                  37.82   $                    7.60  
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Faroe Islands HIC 48,497  $          55,822.91   $                        -     $                        -     $                        -    
Fiji UMIC 883,483  $            6,266.97   $               179.91   $               217.04   $               114.97  
Finland HIC 5,518,050  $          50,152.34   $            4,117.26   $            4,955.28   $            3,185.11  
France HIC 66,987,244  $          41,463.64   $            4,263.36   $            4,679.31   $            3,534.15  
French Polynesia HIC 277,679  $          14,323.82   $                        -     $                        -     $                        -    
Gabon UMIC 2,119,275  $            7,952.53   $               220.35   $               269.96   $               142.32  
Gambia, The LIC 2,280,102  $               716.12   $                  20.93   $                  25.87   $                    3.89  
Georgia UMIC 3,731,000  $            4,717.14   $               308.03   $               479.29   $               112.59  
Germany HIC 82,927,922  $          47,603.03   $            4,714.26   $            5,299.28   $            3,991.60  
Ghana LMIC 29,767,108  $            2,202.31   $                  67.51   $                  93.04   $                  25.89  
Gibraltar HIC 33,718  $                        -     $                        -     $                        -     $                        -    
Greece HIC 10,727,668  $          20,324.25   $            1,510.67   $            2,029.49   $               917.64  
Greenland HIC 56,025  $          48,181.87   $                        -     $                        -     $                        -    
Grenada UMIC 111,454  $          10,640.50   $               516.42   $               814.79   $               213.49  
Guam HIC 165,768  $          35,712.56   $                        -     $                        -     $                        -    
Guatemala UMIC 17,247,807  $            4,549.01   $               241.35   $               370.09   $                  89.82  
Guinea LIC 12,414,318  $               878.60   $                  37.46   $                  56.10   $                    4.61  
Guinea-Bissau LIC 1,874,309  $               777.97   $                  39.05   $                  52.88   $                  17.28  
Guyana UMIC 779,004  $            4,979.00   $               192.27   $               259.68   $               113.32  
Haiti LIC 11,123,176  $               868.34   $                  37.72   $                  53.47   $                    5.79  
Honduras LMIC 9,587,522  $            2,500.11   $               199.55   $               289.38   $                  91.61  
Hong Kong SAR, China HIC 7,451,000  $          48,675.62   $               312.58   $               312.58   $               197.84  
Hungary HIC 9,768,785  $          16,161.98   $               942.59   $            1,222.53   $               620.82  
Iceland HIC 353,574  $          73,191.12   $            5,063.61   $            5,917.79   $            4,127.35  
India LMIC 
1,352,617,3
28  $            2,009.98   $                  62.72   $               103.22   $                  15.95  
Indonesia LMIC 
267,663,43
5  $            3,893.60   $               111.55   $               153.20   $                  49.90  
Iran, Islamic Rep. UMIC 81,800,269  $            5,627.75   $               415.39   $               576.54   $               226.49  
Iraq UMIC 38,433,600  $            5,834.17   $               152.64   $               272.44   $                  32.24  
Ireland HIC 4,853,506  $          78,806.43   $            4,758.59   $            5,376.76   $            3,429.35  
Isle of Man HIC 84,077  $          80,989.17   $                        -     $                        -     $                        -    
Israel HIC 8,883,800  $          41,715.03   $            2,837.14   $            3,488.89   $            1,773.23  
Italy HIC 60,431,283  $          34,483.20   $            2,738.71   $            3,371.50   $            2,039.36  
Jamaica UMIC 2,934,855  $            5,354.24   $               296.25   $               362.59   $               179.41  
Japan HIC 
126,529,10
0  $          39,289.96   $            4,233.03   $            4,802.47   $            3,538.21  
Jordan UMIC 9,956,011  $            4,241.79   $               223.54   $               286.09   $               141.34  
Kazakhstan UMIC 18,276,499  $            9,812.60   $               262.01   $               355.18   $               154.04  
Kenya LMIC 51,393,010  $            1,710.51   $                  66.21   $                  84.56   $                  23.95  
Kiribati LMIC 115,847  $            1,625.29   $               188.05   $               188.22   $               115.62  
Korea, Dem. People’s Rep. LIC 25,549,819  $                        -     $                        -     $                        -     $                        -    
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Korea, Rep. HIC 51,635,256  $          31,362.75   $            2,043.86   $            2,724.68   $            1,209.04  
Kosovo UMIC 1,845,300  $            4,302.28   $                        -     $                        -     $                        -    
Kuwait HIC 4,137,309  $          33,994.41   $            1,068.32   $            1,240.44   $               896.20  
Kyrgyz Republic LMIC 6,315,800  $            1,281.36   $                  72.88   $               114.85   $                  28.50  
Lao PDR LMIC 7,061,507  $            2,542.49   $                  55.21   $                  80.86   $                  17.89  
Latvia HIC 1,926,542  $          17,860.62   $               874.20   $            1,263.72   $               477.60  
Lebanon UMIC 6,848,925  $            8,269.79   $               662.13   $               874.91   $               345.18  
Lesotho LMIC 2,108,132  $            1,299.15   $                  85.52   $               101.67   $                  54.57  
Liberia LIC 4,818,977  $               677.32   $                  68.31   $               100.60   $                    9.73  
Libya UMIC 6,678,567  $            7,241.70   $                        -     $               114.62   $                        -    
Liechtenstein HIC 37,910  $        165,028.25   $                        -     $                        -     $                        -    
Lithuania HIC 2,789,533  $          19,153.41   $               987.95   $            1,307.45   $               648.12  
Luxembourg HIC 607,728  $        116,639.89   $            6,271.44   $            6,975.98   $            5,092.72  
Macao SAR, China HIC 631,636  $          87,208.54   $                        -     $                        -     $                        -    
Madagascar LIC 26,262,368  $               527.50   $                  24.12   $                  29.51   $                  11.49  
Malawi LIC 18,143,315  $               389.40   $                  29.59   $                  32.96   $                    8.30  
Malaysia UMIC 31,528,585  $          11,373.23   $               361.52   $               497.44   $               182.47  
Maldives UMIC 515,696  $          10,330.62   $            1,047.84   $            1,247.99   $               760.31  
Mali LIC 19,077,690  $               899.66   $                  29.79   $                  40.30   $                    9.41  
Malta HIC 483,530  $          30,098.28   $            2,327.78   $            3,137.27   $            1,469.08  
Marshall Islands UMIC 58,413  $            3,788.16   $               851.34   $               928.00   $               448.16  
Mauritania LMIC 4,403,319  $            1,188.83   $                  46.77   $                  70.58   $                  17.14  
Mauritius UMIC 1,265,303  $          11,238.69   $               553.10   $               819.47   $               243.98  
Mexico UMIC 
126,190,78
8  $            9,673.44   $               461.79   $               648.25   $               240.81  
Micronesia, Fed. Sts. LMIC 112,640  $            3,568.29   $               386.69   $               396.86   $               107.66  
Moldova LMIC 3,545,883  $            3,227.31   $               171.19   $               250.43   $                  83.53  
Monaco HIC 38,682  $        185,741.28   $            2,939.84   $            3,147.43   $            2,338.81  
Mongolia LMIC 3,170,208  $            4,121.73   $               140.71   $               191.18   $                  79.75  
Montenegro UMIC 622,345  $            8,844.24   $               531.73   $               659.80   $               398.90  
Morocco LMIC 36,029,138  $            3,237.88   $               171.45   $               254.80   $                  80.33  
Mozambique LIC 29,495,962  $               498.96   $                  19.21   $                  20.68   $                  10.25  
Myanmar LMIC 53,708,395  $            1,325.95   $                  62.11   $               108.06   $                  12.48  
Namibia UMIC 2,448,255  $            5,931.45   $               402.76   $               433.84   $               249.29  
Nauru UMIC 12,704  $            9,888.89   $            1,012.35   $            1,024.03   $               614.59  
Nepal LIC 28,087,871  $            1,033.91   $                  45.45   $                  70.65   $                    8.44  
Netherlands HIC 17,231,017  $          53,024.06   $            4,742.03   $            5,285.06   $            3,839.93  
New Caledonia HIC 284,060  $          12,579.60   $                        -     $                        -     $                        -    
New Zealand HIC 4,885,500  $          41,945.33   $            3,745.22   $            4,253.65   $            2,945.76  
Nicaragua LMIC 6,465,513  $            2,028.89   $               188.16   $               248.79   $               115.43  
Niger LIC 22,442,948  $               413.98   $                  22.68   $                  35.96   $                    5.51  
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Nigeria LMIC 
195,874,74
0  $            2,028.18   $                  79.34   $               139.01   $                  10.33  
North Macedonia UMIC 2,082,958  $            6,083.72   $               327.84   $               443.93   $               208.40  
Northern Mariana Islands HIC 56,882  $          23,258.68   $                        -     $                        -     $                        -    
Norway HIC 5,314,336  $          81,697.25   $            7,477.90   $            8,563.66   $            6,365.95  
Oman HIC 4,829,483  $          16,415.16   $               648.28   $               686.61   $               577.88  
Pakistan LMIC 
212,215,03
0  $            1,482.40   $                  39.58   $                  65.40   $                  11.04  
Palau HIC 17,907  $          15,859.43   $            1,674.09   $            1,916.07   $            1,000.51  
Panama HIC 4,176,873  $          15,575.07   $            1,040.67   $            1,326.08   $               682.70  
Papua New Guinea LMIC 8,606,316  $            2,730.27   $                  55.15   $                  59.48   $                  38.61  
Paraguay UMIC 6,956,071  $            5,821.81   $               327.24   $               451.12   $               168.93  
Peru UMIC 31,989,256  $            6,941.24   $               316.44   $               405.95   $               202.75  
Philippines LMIC 
106,651,92
2  $            3,102.71   $               129.43   $               199.25   $                  40.83  
Poland HIC 37,978,548  $          15,420.91   $               809.01   $               994.64   $               563.89  
Portugal HIC 10,281,762  $          23,407.91   $            1,800.86   $            2,300.63   $            1,194.94  
Puerto Rico HIC 3,195,153  $          31,651.35   $                        -     $                        -     $                        -    
Qatar HIC 2,781,677  $          68,793.78   $            1,827.06   $            1,983.29   $            1,491.39  
Romania UMIC 19,473,936  $          12,301.19   $               476.37   $               575.21   $               372.46  
Russian Federation UMIC 
144,478,05
0  $          11,288.87   $               469.13   $               659.06   $               267.17  
Rwanda LIC 12,301,939  $               772.94   $                  48.08   $                  51.14   $                  16.29  
Samoa UMIC 196,130  $            4,183.41   $               227.15   $               254.14   $               173.50  
San Marino HIC 33,785  $          48,494.55   $            3,012.79   $            3,578.91   $            2,421.99  
Sao Tome and Principe LMIC 211,028  $            2,001.14   $               105.13   $               120.28   $                  41.94  
Saudi Arabia HIC 33,699,947  $          23,338.96   $            1,147.33   $            1,311.91   $               777.91  
Senegal LMIC 15,854,360  $            1,521.95   $                  52.61   $                  79.84   $                  18.19  
Serbia UMIC 6,982,084  $            7,246.73   $               494.42   $               694.68   $               286.79  
Seychelles HIC 96,762  $          16,433.94   $               596.92   $               609.36   $               572.88  
Sierra Leone LIC 7,650,154  $               533.99   $                  86.31   $               122.17   $                    9.64  
Singapore HIC 5,638,676  $          64,581.94   $            2,462.39   $            3,230.00   $            1,342.62  
Sint Maarten (Dutch part) HIC 40,654  $                        -     $                        -     $                        -     $                        -    
Slovak Republic HIC 5,447,011  $          19,442.71   $            1,178.74   $            1,388.90   $               941.10  
Slovenia HIC 2,067,372  $          26,123.97   $            1,834.16   $            2,054.30   $            1,325.87  
Solomon Islands LMIC 652,858  $            2,137.69   $               106.34   $               111.23   $                  73.62  
Somalia LIC 15,008,154  $               314.54   $                        -     $                        -     $                        -    
South Africa UMIC 57,779,622  $            6,374.03   $               428.18   $               461.36   $               230.06  
South Sudan LIC 10,975,920  $            1,119.65   $                        -     $                        -     $                        -    
Spain HIC 46,723,749  $          30,370.89   $            2,389.89   $            2,959.31   $            1,702.51  
Sri Lanka UMIC 21,670,000  $            4,102.48   $               153.10   $               229.83   $                  65.97  
St. Kitts and Nevis HIC 52,441  $          19,275.42   $               930.77   $            1,410.18   $               401.81  
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St. Lucia UMIC 181,889  $          10,566.05   $               489.76   $               728.28   $               205.70  
St. Martin (French part) HIC 37,264  $                        -     $                  66.14   $                  66.14   $                  29.95  
St. Vincent and the Grenadines UMIC 110,210  $            7,361.40   $               250.22   $               301.51   $               192.06  
Sudan LMIC 41,801,533  $               977.27   $               152.02   $               264.36   $                  29.62  
Suriname UMIC 575,991  $            6,234.04   $               356.05   $               433.74   $               246.99  
Sweden HIC 10,183,175  $          54,608.36   $            5,710.59   $            6,581.11   $            4,768.65  
Switzerland HIC 8,516,543  $          82,796.55   $            9,835.96   $          12,743.65   $            6,174.88  
Syrian Arab Republic LIC 16,906,283  $            2,032.62   $                        -     $                  35.51   $                        -    
Tajikistan LIC 9,100,837  $               826.62   $                  55.70   $                  92.49   $                  15.93  
Tanzania LIC 56,318,348  $            1,050.68   $                  35.50   $                  43.27   $                  14.42  
Thailand UMIC 69,428,524  $            7,273.56   $               221.92   $               248.80   $               173.40  
Timor-Leste LMIC 1,267,972  $            2,035.53   $                  79.89   $                  86.99   $                  44.55  
Togo LIC 7,889,094  $               679.26   $                  38.77   $                  58.32   $                    7.77  
Tonga UMIC 103,197  $            4,364.02   $               203.15   $               225.45   $               133.87  
Trinidad and Tobago HIC 1,389,858  $          17,129.91   $            1,063.83   $            1,490.22   $               561.62  
Tunisia LMIC 11,565,204  $            3,447.51   $               256.50   $               358.85   $               145.27  
Turkey UMIC 82,319,724  $            9,370.18   $               468.65   $               545.82   $               367.62  
Turkmenistan UMIC 5,850,908  $            6,966.64   $               422.85   $               745.03   $                  78.40  
Turks and Caicos Islands HIC 37,665  $          27,142.23   $            1,578.44   $            1,578.44   $               601.94  
Tuvalu UMIC 11,508  $            3,700.71   $               507.35   $               510.73   $               428.80  
Uganda LIC 42,723,139  $               642.78   $                  37.61   $                  52.77   $                    6.23  
Ukraine LMIC 44,622,516  $            3,095.17   $               141.19   $               217.91   $                  59.88  
United Arab Emirates HIC 9,630,959  $          43,004.95   $            1,323.12   $            1,568.76   $               958.96  
United Kingdom HIC 66,488,991  $          42,943.90   $            3,958.02   $            4,556.39   $            3,175.33  
United States HIC 
327,167,43
4  $          62,794.59   $            9,869.74   $          10,963.97   $            8,077.93  
Uruguay HIC 3,449,299  $          17,277.97   $            1,379.10   $            1,618.66   $               988.73  
Uzbekistan LMIC 32,955,400  $            1,532.37   $               135.11   $               205.70   $                  62.32  
Vanuatu LMIC 292,680  $            3,123.89   $               109.81   $               119.06   $                  59.16  
Venezuela, RB UMIC 28,870,195  $          16,054.49   $                        -     $               445.83   $                        -    
Vietnam LMIC 95,540,395  $            2,566.60   $               122.84   $               177.59   $                  58.27  
Virgin Islands (U.S.) HIC 106,977  $          35,938.02   $                        -     $                        -     $                        -    
West Bank and Gaza LMIC 4,569,087  $            3,198.87   $                        -     $                        -     $                        -    
Yemen, Rep. LIC 28,498,687  $               944.41   $                  72.04   $               130.36   $                    7.34  
Zambia LMIC 17,351,822  $            1,539.90   $                  56.54   $                  63.40   $                  21.65  
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